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The autosomal recessive immunodeficiency, centromeric instability, and facial anomalies (ICF) syndrome is a genetically
heterogeneous disorder. Despite the identification of the underlying gene defects, it is unclear howmutations in any of the four
known ICF genes cause a primary immunodeficiency. Here we demonstrate that loss of ZBTB24 in B cells from mice and ICF2
patients affects nonhomologous end-joining (NHEJ) during immunoglobulin class-switch recombination and consequently
impairs immunoglobulin production and isotype balance. Mechanistically, we found that ZBTB24 associates with poly(ADP-
ribose) polymerase 1 (PARP1) and stimulates its auto-poly(ADP-ribosyl)ation. The zinc-finger in ZBTB24 binds PARP1-
associated poly(ADP-ribose) chains and mediates the PARP1-dependent recruitment of ZBTB24 to DNA breaks. Moreover,
through its association with poly(ADP-ribose) chains, ZBTB24 protects them from degradation by poly(ADP-ribose)
glycohydrolase (PARG). This facilitates the poly(ADP-ribose)-dependent assembly of the LIG4/XRCC4 complex at DNA
breaks, thereby promoting error-free NHEJ. Thus, we uncover ZBTB24 as a regulator of PARP1-dependent NHEJ and class-
switch recombination, providing a molecular basis for the immunodeficiency in ICF2 syndrome.
Introduction
Immunodeficiency with centromeric instability and facial anoma-
lies (ICF) syndrome (OMIM 242860; 614069) is a rare autosomal
recessive disorder characterized by a triad of phenotypes
(Hagleitner et al., 2008; Weemaes et al., 2013). Patients suffer from
a variable immunodeficiency, mainly characterized by hypo- or
agammaglobulinemia in the presence of B cells, resulting in re-
current and often fatal respiratory and gastrointestinal infections.
Furthermore, patients often present with a distinct set of facial
anomalies, including a flat nasal bridge, hypertelorism, and epi-
canthal folds. The cytogenetic hallmark of the disease is centromeric
instability, specifically at chromosomes 1, 9, and 16, which is asso-
ciated with CpG hypomethylation of the pericentromeric satellite II
and III repeats.
ICF syndrome is genetically heterogeneous and can be sub-
divided into five different groups (ICF1-4 and ICFX) based on the
genetic defect underlying the phenotype (Thijssen et al., 2015;
Weemaes et al., 2013). ICF1 patients, comprising ∼50% of the
total patient population, carry mutations in the de novo DNA
methyltransferase 3B gene (DNMT3B, ICF1; Hansen et al., 1999;
Xu et al., 1999). Approximately 30% of the cases have muta-
tions in the zinc-finger and BTB (bric-a-bric, tramtrack, broad
complex)-containing 24 gene (ZBTB24, ICF2; Chouery et al.,
2012; de Greef et al., 2011; Nitta et al., 2013). Finally, muta-
tions in the cell division cycle–associated protein 7 (CDCA7,
ICF3) or helicase, lymphoid-specific (HELLS, ICF4) were also
reported in patients (∼20% of the total patient population),
leaving only a few cases genetically unaccounted for (ICFX;
Thijssen et al., 2015). Remarkably, however, although the
genetic defects underlying ICF syndrome have been mostly
elucidated, it remains largely unclear how these defects lead
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to ICF syndrome, in particular the characteristic life-threatening
immunodeficiency.
Interestingly, the number of circulating B lymphocytes in ICF
patients is normal, but a lack of switched memory B cells and an
increased proportion of immature B cells have been reported
(Blanco-Betancourt et al., 2004), suggesting a defect in the final
stages of B cell differentiation. A key step in B cell maturation is
isotype switching of Igs through class-switch recombination
(CSR). Effective CSR heavily relies on the controlled formation
and correct repair of DNA double-strand breaks (DSBs) induced
by activation-induced (cytidine) deaminase (AID) at conserved
motifs within the switch (S) regions, which are upstream from
gene segments that encode distinct constant regions of antibody
heavy chains (Alt et al., 2013). Upon break formation, two S
regions are rejoined by nonhomologous end-joining (NHEJ), the
main cellular pathway to repair DSBs (Alt et al., 2013). This leads
to loss of the intervening DNA between the S regions, removal of
μ and δ heavy chain constant regions, substitution by a γ, α, or ε
constant region, and consequently a change in the class of im-
munoglobulins that is expressed by a B cell.
NHEJ is performed by the concerted action of the DNA-
dependent protein–kinase complex (DNA-PK), comprised of
the KU70/KU80 heterodimer and the DNA-PK catalytic subunit
(DNA-PKcs), and the downstream effector proteins x-ray repair
cross-complementing protein 4 (XRCC4), DNA ligase 4 (LIG4),
and nonhomologous end-joining factor 1 (NHEJ1; Alt et al., 2013).
In the absence of this canonical NHEJ (c-NHEJ) mechanism, ef-
fective CSR is significantly impaired but not absent, as DSB re-
pair is performed by alternative NHEJ (a-NHEJ). a-NHEJ is a
poorly characterized process dependent on poly(ADP-ribose)
polymerase 1 (PARP1), XRCC1, and DNA ligases 1 and 3 (LIG1 and
LIG3; Audebert et al., 2004; Lu et al., 2016; Paul et al., 2013).
Recent studies have also revealed a role for PARP1 in c-NHEJ
(Luijsterburg et al., 2016).
Mutations in NHEJ genes (e.g., DNA-PKcs and LIG4) are in-
creasingly recognized as the primary cause of immunodefi-
ciency (Woodbine et al., 2014). Considering the similarities
between the immunodeficiency in ICF patients and individuals
with defective NHEJ, the question arises whether loss of NHEJ
might explain the compromised immune system in ICF patients.
Here we demonstrate that ICF2 patient-derived B cells are de-
fective in NHEJ during CSR. Mechanistically, we uncover a
regulatory function for ZBTB24 in NHEJ by cooperating with
PARP1 and XRCC4/LIG4 during this repair process. This pro-
vides a molecular basis for the humoral immunodeficiency in
ICF2 patients.
Results
ICF2 patients display features of defective CSR
The immunodeficiency in ICF2 syndrome is characterized by a
reduction or even an absence of Igs (hypo- or agammaglobu-
linemia) and decreased numbers of switched memory B cells,
while normal levels of total B cells are observed (de Greef et al.,
2011; Weemaes et al., 2013). We corroborated these findings by
showing hypogammaglobulinemia in sera of four independent
ICF2 patients but normal serum levels in age-matched controls
(Table S1). Moreover, we characterized peripheral blood lym-
phocytes by immunophenotyping and found a decrease in the
number of switched memory B cells, whereas numbers of total
B cells, naive B cells, and unswitched memory B cells were un-
affected (Fig. 1 A). Of note, total numbers of CD4+ T cells, as well
as naive, central memory, and CD27+CD28+ early antigen expe-
rienced CD4+ T cells were increased compared with age-matched
controls, whereas those for CD8+ T cells were normal (Fig. S1, A
and B).
These findings could suggest a defect in V(D)J recombination
or CSR, which are processes that are critical for B cell develop-
ment and ultimately define antibody production and diversifi-
cation. We therefore first examined the combinatorial diversity
of VDJ usage and composition of the junctional region during
V(D)J recombination by sequencing Ig heavy chain gene re-
arrangements in B cells derived from peripheral blood mono-
nuclear cells (PBMCs) of three ICF2 patients. The usage of V, D,
and J gene segments, as well as the composition of the junctional
regions, meaning the number of nucleotide deletions and in-
sertions of nontemplated nucleotides by terminal deoxy-
nucleotidyl transferase (TdT; N-nucleotides), in these patients
resembled that of controls (Fig. S1, C–E). This suggests that
ICF2 patients do not suffer from major defects in V(D)J
recombination.
To examine impairment in CSR, we first stimulated PBMCs
in vitro and measured the production of total IgA and IgG. For all
patients analyzed, the capacity to produce IgA and IgG
in vitro was significantly impaired compared with healthy
controls (Fig. 1 B), which is in line with the hypo- or agam-
maglobulinemia and reduced numbers of switched memory
B cells observed in these patients (Fig. 1 A; de Greef et al.,
2011; Weemaes et al., 2013). We then performed sequencing
analysis of IgG transcripts in patient-derived PBMCs and
determined the relative abundance of IgG subclasses. When
comparing relative abundance of IgG1–4 to age-matched
controls, we observed a decrease in the relative expression
of IgG1, accompanied by an increase in relative IgG3 ex-
pression in ICF2 patients (Fig. 1 C), which is indicative of
impaired CSR.
To investigate how CSR is affected in ICF2, we isolated naive
B cells from two ICF2 patients and three healthy donors and
stimulated these cells with CD40L, IL21, IL10, and aIgM for 6 d.
To determine whether this treatment could initiate the CSR
process, we measured AID expression and germline tran-
scripts after 6 d of culture. In both ICF2 patients and controls,
AID expression (Fig. 1 D), as well germline transcription
(Fig. 1, E and F), was induced upon stimulation. However,
despite the induction of AID and germline transcription, the
formation of IgG+ and IgA+ B cells was severely hampered in
ICF2 patients (Fig. 1 G), which indicates an impairment in the
final stages of CSR involving the repair of AID-induced DSBs.
In line with the reduced number of IgG+ and IgA+ B cells, the
production of IgG, and to a lesser degree IgA, was also severely
reduced in ICF2 patients (Fig. 1 H). Together, these data show
that although CSR can be initiated normally, it cannot be
completed in B cells from ICF2 patients, probably owing to
impaired DSB repair.
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Figure 1. Defective CSR in ICF2 patients due to loss of ZBTB24-dependent NHEJ. (A) The number of cells in the indicated differentiation stages of the total
peripheral blood CD19+/CD20+ B cell population was measured by flow cytometry. Naive B cells, IgMdull, IgD2+, CD27−; unswitched memory B cells, IgM2+,
IgDdull, CD27+; switched memory B cells, IgM−, IgD−, CD27+. Four ICF2 patients and eight healthy age-matched controls (age range 0.8–4.3 yr) were analyzed.
Statistical significance was calculated using Student’s t test (***, P < 0.001; ns, not significant). (B) PBMCs were stimulated with CD40L, aIgM, CpG, and IL-21.
After 7 d, IgG and IgA concentrations were determined by ELISA. Three ICF2 patients and five adult controls were analyzed. n.d., not detectable. Statistical
significance was calculated using Student’s t test (*, P < 0.05; **, P < 0.01). (C) Frequency of IgG subclass usage with unique switched IGG transcripts. The
mean ± SEM of three ICF2 patients and four healthy controls is shown. Statistical significance was calculated using χ2 test (*, P < 0.05; ***, P < 0.001). (D)
Naive B cells from two ICF2 patients and three healthy controls were stimulated with CD40L, aIgM, IL-10, and IL-21 or left unstimulated. After 6 d, relative
expression of AID transcripts in unstimulated and stimulated cells was determined using RT-qPCR. The mean ± SD of two technical replicates is shown.
Statistical significance was calculated using Student’s t test (ns, not significant). (E) As in D, except that Iα1-Cα1 and Iα2-Cα2 germline transcripts were
amplified by PCR. PCR products were resolved on a 1% agarose gel. (F)Quantification of the intensity of the expected bands from Ewith ImageJ. The mean ± SD
of two technical replicates is shown. Statistical significance was calculated using Student’s t test (ns, not significant). (G) As in D, except that the percentage of
IgG+ and IgA+ CD19 B cells was determined with flow cytometry. The mean ± SD of two technical replicates is shown. Statistical significance was calculated
using Student’s t test (***, P < 0.001; ****, P < 0.0001; ns, not significant). (H) As in D, except that after 10 d of culture, IgG and IgA concentrations were
determined by ELISA. The mean of two technical replicates is shown. Statistical significance was calculated using Student’s t test (*, P < 0.05).
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Loss of ZBTB24 resembles NHEJ deficiency in CSR
CSR heavily relies on the c-NHEJ–mediated repair of AID-
induced DSBs upstream of the constant regions of the IgH lo-
cus (Alt et al., 2013). To study the functional consequences of
ZBTB24 mutations in the repair of DSBs during CSR, a PCR-
based assay for amplification of Sµ-Sα junctions (located up-
stream of the Cμ and Cα regions of the IgH locus, respectively)
was performed on ICF2-patient cells. 82 Sµ-Sα junctions were
amplified from these patients and compared with 213 (30 newly
generated and 183 previously published) Sµ-Sα junctions from
healthy children who served as controls (Du et al., 2008;
Enervald et al., 2013). The junctions from ICF2 patients showed
an altered repair pattern with a decrease in direct end-joining
(5% versus 16% in controls, χ2 test, P = 0.0109; Table 1, Data S1,
and Data S2), a decrease in small insertions (13% versus 24% in
controls, χ2 test, P = 0.0389; Table 1, Data S1, and Data S2), and an
increased usage of long (≥7 bp) microhomologies (40% versus
24% in controls, χ2 test, P = 0.0041; Table 1, Data S1, and Data S2),
suggesting a shift to the use of an alternative end-joining path-
way in cells from these patients. A similar shift is also apparent
in c-NHEJ–deficient cells from patients with mutations in LIG4
or Artemis (Table 1, Data S1, and Data S2), suggesting that the
shift to alternative repair may be due to a defect in c-NHEJ.
Furthermore, 46 Sµ-Sγ junctions (located upstream of the Cμ
and Cγ regions of the IgH locus, respectively) were isolated from
the ICF2-deficient cells and compared with our previously
published 58 Sµ-Sγ junctions from healthy controls (Du et al.,
2008). Similar to patients with mutations in LIG4 or Artemis,
the repair patterns at the Sµ-Sγ junctions were largely normal in
ICF2 patients (Table 1 and Data S3), although one Sµ-Sγ junction
showed a “footprint” of sequential switching (Sμ-Sγ3-Sγ2; 9%),
which is rarely observed in controls (2%) but frequently seen in
c-NHEJ–defective cells such as Artemis- or DNA-PKcs–deficient
cells (Bjo¨rkman et al., 2015; Du et al., 2008). Thus, the altered
CSR patterns in ICF2 patient cells and their resemblance to those
observed in several known c-NHEJ–deficient patients suggest
that ZBTB24 might be a novel NHEJ factor involved in CSR.
ZBTB24 promotes DSB repair via c-NHEJ
To assess whether ZBTB24 is involved in NHEJ, which is the
dominant pathway for the repair of DSBs in mammalian cells,
we made use of the well-established HEK293T EJ5-GFP reporter
cell line (Fig. 2 A; Bennardo et al., 2008). Depletion of ZBTB24 by
multiple siRNAs resulted in a marked decrease in NHEJ, which
was comparable to the impact of depleting XRCC4 (Fig. 2, B and
C; and Fig. S2 A). Cell cycle profiles remained unaffected in these
cells, ruling out effects of cell cycle misregulation (Fig. S2 B). To
corroborate these findings, we also used fibroblasts containing
the GC92 reporter (Fig. S2 C; Taty-Taty et al., 2016). Depletion of
ZBTB24 by two different siRNAs resulted in a marked decrease
in NHEJ, which was comparable to the impact of depleting KU80
and reminiscent of the effect on NHEJ observed in the EJ5-GFP
reporter (Fig. 2, B and C; and Fig. S2, D and E).
The two major known pathways for the end-joining–dependent
repair of DSBs in mammalian cells are c-NHEJ and a-NHEJ (Alt
et al., 2013). Although the EJ5-GFP and GC92 reporters cannot
differentiate between these pathways, we observed a re-
markably similar phenotype after loss of ZBTB24 and the
c-NHEJ factors XRCC4 and KU80 (Fig. 2, B and C; and Fig. S2, D
and E). Moreover, ICF2 patient cells showed altered CSR
patterns that resembled those observed in patient cells defi-
cient for the c-NHEJ factor LIG4 (Table 1, Data S1, Data S2, and
Data S3), suggesting a role for ZBTB24 in c-NHEJ. To provide
further support for this, we used a plasmid integration assay
Table 1. Characterization of CSR junctionsa
Study subjects Perfectly matched short homology No. of junctions
0 bp
Direct end-joining Small insertions 1–6 bp ≥7 bp
Sµ-Sα
ICF2-deficienta 4 (5)*↓ 11 (13)*↓ 34 (42) 33 (40)**↑ 82
Lig4-deficientb 1 (3) 0 (0)**↓ 11 (37) 18 (60)****↑ 30
Artemis-deficientc 0 (0)**↓ 6 (11)*↓ 18 (33) 30 (56)****↑ 54
Controls (1–13 yr)d 34 (16) 52 (24) 77 (36) 50 (24) 213
Sµ-Sγ
ICF2-deficienta 9 (20) 3 (7) 34 (74) 0 (0) 46
Lig4-deficientb 4 (12) 11 (32) 19 (56) 0 (0) 34
Artemis-deficientc 5 (21) 4 (17) 15 (63) 0 (0) 24
Controls (1–6 yr)e 13 (22) 9 (16) 36 (62) 0 (0) 58
Data are n (%). Statistical analysis was performed by χ2 test. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
aThe sequences of Sµ-Sα and Sµ-Sγ junctions are available in Data S1 and Data S2, respectively.
bPreviously published CSR junctions from Lig4-deficient patients (Pan-Hammarstro¨m et al., 2005).
cPreviously published CSR junctions from Artemis-deficient patients (Du et al., 2008).
dNewly acquired and previously published Sµ-Sα junctions from children controls (Du et al., 2008; Enervald et al., 2013).
ePreviously published Sµ-Sγ junctions from children controls (Du et al., 2008).
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to specifically study the role of ZBTB24 in c-NHEJ (Fig. 2 D).
Depletion of DNA-PKcs (catalytic subunit of DNA-PK complex)
resulted in an 80–90% decrease in cell survival (Fig. 2 E and Fig.
S2 F), indicating that the assay provides a readout for c-NHEJ as
reported previously (Caron et al., 2019; Luijsterburg et al., 2016).
Moreover, knockdown of ZBTB24 caused a ∼50% reduction in
c-NHEJ efficiency compared with control cells (Fig. 2, E and F;
and Fig. S2 A).
Figure 2. ZBTB24 promotes DSB repair via c-NHEJ. (A) Schematic representation of the EJ5-GFP reporter for NHEJ. (B) HEK293T EJ5-GFP cells were treated
with the indicated siRNAs and, 48 h later, cotransfected with I-SceI (pCBASce) and mCherry expression vectors. The ratio of GFP/mCherry-expressing cells was
counted by flow cytometry 48 h later. The mean ± SD of two independent experiments is shown. Statistical significance was calculated using Student’s t test
(*, P < 0.05). (C) Cells from B were subjected to RNA extraction. cDNA was synthesized from total RNA samples followed by qPCR to determine the expression
levels of ZBTB24. The mean ± SEM of two independent experiments is shown. Statistical significance was calculated using Student’s t test (**, P < 0.01; ***,
P < 0.001). (D) Schematic of the plasmid integration assay. pEGFP-C1 plasmid containing Neo and GFP markers is linearized with the indicated restriction
enzymes and transfected into U2OS cells. Stable integrants are selected on medium containing G418. GFP was used as a control for transfection efficiency.
(E) Plasmid integration assays in U2OS cells transfected with the indicated siRNAs. The mean ± SEM of two to four independent experiments is shown.
Statistical significance was calculated using Student’s t test (**, P < 0.01; ****, P < 0.0001). (F) As in C, except that cells from E were used. The mean ± SEM of
two independent experiments is shown. Statistical significance was calculated using Student’s t test (**, P < 0.01; ***, P < 0.001). (G) VH10-SV40 cells were
treated with the indicated siRNAs for 48 h, exposed to different doses of IR, and scored for clonogenic survival. The mean ± SEM of two independent ex-
periments is shown. (H) As in C, except that cells from G were used to monitor XRCC4 expression. The mean ± SEM of two independent experiments is shown.
Statistical significance was calculated using Student’s t test (***, P < 0.001). (I) As in C, except that cells from G were used. The mean ± SEM of two in-
dependent experiments is shown. Statistical significance was calculated using Student’s t test (***, P < 0.001).
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To rule out that ZBTB24 regulates NHEJ indirectly through
transcriptional regulation of DSB repair factors, we depleted
ZBTB24 and performed whole-transcriptome analysis using
RNA sequencing in HEK293T cells (Fig. S2 G). In total, we found
158 differentially expressed genes (false discovery rate < 0.05),
of which 90 were up-regulated and 68 were down-regulated
(Table S2). We compared the list of deregulated genes with 66
unique genes in gene ontology term 0006302 (DSB repair), but
we did not find any overlapping genes (Fig. S2 G). This suggests
that ZBTB24 does not affect NHEJ through transcription regu-
lation of DSB repair genes.
To assess the functional relevance of ZBTB24 in NHEJ, we
investigated its ability to protect cells against DNA breaks in-
duced by ionizing radiation (IR). To this end, clonogenic survival
of VH10-SV40 cells depleted for ZBTB24 or XRCC4 was deter-
mined after exposure to IR. This showed a similar dose-dependent
decrease in the survival capacity of ZBTB24-depleted and
XRCC4-depleted cells compared with control cells (siLuc;
Fig. 2, G–I). Surprisingly, however, ICF2 patient-derived fi-
broblast cells did not show sensitivity to IR (Fig. S2 H). To
corroborate these findings, we generated ZBTB24 KO U2OS
cells using CRISPR/Cas9-based genome editing. Two inde-
pendent ZBTB24 KO clones also did not display IR sensitivity,
although these clones showed the previously reported re-
duction in CDCA7 expression (Fig. S2, I–K; Wu et al., 2016).
Thus, the NHEJ phenotype is specifically observed in B cells
from ICF2 patients and after short-term loss of ZBTB24 in
differentiated human cells. These results underscore the
functional importance of ZBTB24 in the protection of cells
against DNA breaks and implicate a role for ZBTB24 in DSB
repair by NHEJ.
ZBTB24 interacts with PARP1 in a PARylation-dependent
manner
To assess how ZBTB24 affects NHEJ, we aimed to identify its
interaction partners using an unbiased, quantitative proteomics
approach. To this end, we expressed GFP-ZBTB24 or GFP (con-
trol) in U2OS cells and performed GFP-trap-based im-
munoprecipitations (IPs) followed by mass spectrometry (MS)
after stable isotope labeling of amino acids in culture (SILAC;
Fig. 3 A). Our screen identified 110 proteins that were at least
fourfold enriched over control cells (Table S3). Interestingly,
besides all core histones, PARP1, an enzyme implicated in
NHEJ and other DNA repair mechanisms (Ray Chaudhuri and
Nussenzweig, 2017), was among the potential interactors of
ZBTB24 (Fig. 3 A and Table S3). To explore this further, we
performed the reciprocal experiment using cells expressing
GFP-PARP1. This screen identified 21 proteins that were at least
twofold enriched over control cells (Fig. 3 B and Table S4).
Remarkably, not only did we find several known PARP1 in-
teractors such as XRCC1, LIG3, and DNA polymerase β (POLB;
Pines et al., 2013), but ZBTB24 was also among the top hits of
this screen (Fig. 3 B and Table S4). To confirm the ZBTB24–
PARP1 interaction, we performed pulldown IP experiments
followed by Western blot analysis. Endogenous PARP1, as well
as histone H3, were detected after IP of GFP-ZBTB24, whereas
GFP-PARP1 efficiently precipitated Myc-ZBTB24 in the
reciprocal IP (Fig. 3 C and Fig. S3 A). Moreover, using coim-
munoprecipitation experiments, we also confirmed that en-
dogenous PARP1 interacts with endogenous ZBTB24 (Fig. 3 D).
PARP1 can covalently link negatively charged ADP-ribose
units to itself or to other target proteins, forming poly(ADP)-
ribose (PAR) chains through a process known as PARylation
(Pines et al., 2013). Upon addition of PARP inhibitor (PARPi),
PARylation was efficiently inhibited, and the interaction be-
tween ZBTB24 and PARP1 was lost (Fig. 3 C and Fig. S3 B). To-
gether, these results suggest that ZBTB24 and PARP1 interact in
a PARylation-dependent manner.
PARP1 recruits ZBTB24 to sites of DNA damage
PARP1 binds to both single-strand breaks and DSBs, where it
promotes the assembly of chromatin remodelers and DNA repair
proteins (Pines et al., 2013). Given the interaction between
ZBTB24 and PARP1, we tested whether ZBTB24 is recruited to
sites of DNA damage. We found that both N- and C-terminally
tagged ZBTB24 localize at laser microirradiation-induced tracks
containing γH2AX, a known marker of DNA damage (Fig. 3, E
and F). Importantly, ZBTB24 recruitment, but not that of the
DNA damage sensor NBS1, to such DNA damage tracks was
completely abrogated after treatment with PARPi (Fig. 3, G and
H), demonstrating its dependence on PARylation. Furthermore,
the accumulation of ZBTB24 at DNA damage tracks was rapid
but transient, reaching maximum levels at ∼100 s after DNA
damage induction (Fig. 3 H) and greatly resembling the reported
dynamics of PARP1 accrual and PARylation at sites of DNA dam-
age (Mortusewicz et al., 2007). Importantly, siRNA-mediated
depletion of PARP1, but not PARP2, abrogated ZBTB24 accumu-
lation in laser tracks (Fig. 3, I and J). These results show that
ZBTB24 is rapidly recruited to sites of DNA damage in a PARP1-
and PARylation dependent manner.
PAR chains are rapidly hydrolyzed by the activity of poly(-
ADP-ribose) glycohydrolase (PARG), which explains the rapid
turnover of PAR chains at sites of DNA damage (Pines et al.,
2013). To prevent this rapid turnover, we increased the
steady-state levels of PAR chains by siRNA-mediated depletion
of PARG (Fig. S3 C). Under these conditions, we observed en-
hanced and more persistent accumulation of ZBTB24 at sites of
damage (Fig. S3, D and E). In contrast, overexpression of
mCherry-tagged PARG resulted in a dramatic decrease in the
total levels of PARylation and abrogated recruitment of ZBTB24
to sites of damage (Fig. S3, F–H), phenocopying the effect ob-
served after loss of PARP1 activity (Fig. 3, F and G). Thus, the
PARP1- and PARG-dependent turnover of PAR chains at DNA
lesions is a critical determinant of the rapid and transient ac-
cumulation of ZBTB24.
The zinc-finger (ZNF) of ZBTB24 binds PAR to promote PARP1-
dependent ZBTB24 recruitment
Three conserved domains can be identified in ZBTB24: an
N-terminal BTB domain (aa 9–132), a small AT-hook DNA-
binding domain (aa 159–171), and eight tandem C2H2 ZNF mo-
tifs (aa 294–512; Fig. 4 A). To dissect the relevance of these
domains for ZBTB24’s interactionwith PARP1 and localization to
DNA damage sites, we generated and expressed GFP-fusion
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Figure 3. PARP1 interacts with ZBTB24 in a PARylation-dependentmanner and recruits ZBTB24 to sites of DNA damage. (A) Schematic representation
of SILAC-based MS approach. GFP- or GFP-ZBTB24–expressing U2OS cells were labeled with Lys0 and Arg0 (L) or Lys8 and Arg10 (H), respectively. Lysates
were subjected to GFP IP, and equal amounts of both IP fractions were mixed. Proteins in the IP fractions were digested by trypsin and subjected to MS
analysis. A list of ZBTB24-interacting proteins, including the number of peptides and the interaction ratio from heavy (H)- over light (L)-labeled cell extracts as
revealed by MS, is shown. (B) As in A, but with GFP- and GFP-PARP1–expressing U2OS cells. (C) Cells expressing GFP-ZBTB24, GFP-PARP1, and Myc-ZBTB24
or GFP-NLS and Myc-ZBTB24 were treated with either DMSO (Mock) or PARP inhibitor (PARPi). Whole-cell extracts (WCEs) were subjected to GFP IP followed
by Western blot analysis of the indicated proteins. (D) IP of endogenous PARP1 in U2OS cells. IgG is a negative control. Blots were probed for ZBTB24 and
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constructs of the different domains (Fig. 4, B–E). Interestingly,
GFP-BTB, GFP-BTB-AT, or GFP-ΔZNF did not accumulate at sites
of laser-induced DNA damage, whereas GFP-BTB-AT-ZNF (GFP-
BAZ) and GFP-ZNF were recruited with similar kinetics as GFP-
ZBTB24 (Fig. 4 C and Fig. S3, I–L) and in a manner dependent on
PARP activity as well (Fig. S3, I–L). This suggests that the ZNF
domain is required for the PARP1 activity-dependent accumu-
lation of ZBTB24 at sites of DNA damage.
PARP1 is responsible for ∼85% of the synthesized PAR chains
in cells (Mortusewicz et al., 2007; Shieh et al., 1998). The PAR-
dependent accumulation of ZBTB24 could be a consequence of
the PARylation of ZBTB24 or the binding of ZBTB24 to PARP1-
associated PAR chains. To examine whether ZBTB24 itself is
PARylated, we exposed cells to IR or the DNA-alkylating agent
N-methyl-N9-nitro-N-nitrosoguanidine (MNNG) and compared
the PARylation status of ZBTB24 to that of PARP1.We observed a
significant increase in PARylated proteins after MNNG treat-
ment, and a modest increase shortly after exposure to IR (Fig.
S3M), indicating that these treatments result in the activation of
PARP enzymes. Subsequently, we immunoprecipitated GFP-
ZBTB24 or GFP-PARP1 from these cells using stringent, high-salt
wash conditions to disrupt all noncovalent protein–protein in-
teractions and examined their PARylation status by Western
blot analysis. As expected, PARP1 was strongly PARylated under
PARP1. (E) Schematic representation of the laser microirradiation approach. (F) GFP-ZBTB24 or ZBTB24-GFP accumulate at γH2AX-decorated DNA damage
tracks after transient expression and laser microirradiation in U2OS cells. Scale bar, 10 µm. (G) As in F, except that cells transiently expressing GFP-ZBTB24
and mCherry-NBS1 were treated with either DMSO (Mock) or PARPi before GFP-ZBTB24 and mCherry-NBS1 accumulation was monitored at the indicated
time points after laser microirradiation. Scale bar, 10 µm. (H)Quantification of the results from G. The mean ± SEM of two to three independent experiments is
shown. (I) As in G, except that cells were cotransfected with GFP-ZBTB24 and the indicated siRNAs. Scale bar, 10 µm. (J) Quantification of the results from I.
The mean ± SEM of two to three independent experiments is shown (left). Western blot showing the knockdown efficiency of PARP1 and PARP2 (right).
Figure 4. The ZNF domain in ZBTB24 inter-
acts with PAR and mediates its recruitment
to sites of DNA damage. (A) Schematic repre-
sentation of isoform 1 of ZBTB24 and its BTB-,
DNA-binding AT hook- and 8 × C2H2 ZNF domain.
Protein domains were separated as indicated and
fused to GFP for functional analysis. (B) Western
blot analysis of WCEs from U2OS cells expressing
the indicated GFP-tagged ZBTB24 domains. (C)
Accumulation of the indicated GFP-tagged ZBTB24
domain in laser microirradiated U2OS cells. Repre-
sentative images of unirradiated and irradiated cells
(taken at the indicated time point after irradiation)
are shown. Scale bar, 10 µm. (D) HEK293T cells
expressing the indicated GFP-tagged ZBTB24 do-
mains were subjected to GFP IP. GFP-purified pro-
teins were resolved by gel electrophoresis, blotted
onto a membrane, renatured, and incubated with
radioactive PAR (32P-PAR). Recombinant (rec.)
PARP1 is a positive control. (E) Lysates from U2OS
cells transiently expressing either GFP-NLS or the
indicated GFP-tagged ZBTB24 domains were sub-
jected to GFP IP and Western blot analysis for the
indicated proteins.
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all conditions (Fig. S3 N), showing that our approach can detect
the attachment of PAR chains to proteins. However, we failed to
detect PARylation of ZBTB24 under these conditions, suggesting
that ZBTB24 is not a preferred target for PARylation by PARP1
(Fig. S3 N).
Next, we examined whether ZBTB24 could physically asso-
ciate with PAR chains in vitro by using Southwestern blotting.
GFP-ZBTB24 was immunoprecipitated, transferred to a mem-
brane, and exposed to in vitro–generated 32P-labeled PAR
chains. Indeed, GFP-ZBTB24, similar to recombinant PARP1, was
able to bind PAR chains efficiently (Fig. 4 D). Because the ZNF
domain in ZBTB24 is a key determinant of the PARP1 activity-
dependent recruitment of ZBTB24 to sites of DNA damage, we
examined whether this domain would mediate the interaction
with PAR polymers. Indeed, GFP-ZNF, but not GFP-ΔZNF (full-
length ZBTB24 lacking the ZNF domain), was able to bind PAR
chains (Fig. 4 D). In concordance, IP experiments revealed an
interaction between PARP1 and GFP-ZNF, but not GFP-ΔZNF
(Fig. 4 E). Together, these results suggest that the ZNF of ZBTB24
acts as a PAR-binding domain that mediates ZBTB24 recruit-
ment to DNA damage through interactions with PARylated
PARP1.
ZBTB24 promotes PAR synthesis and protects PAR chains
through its ZNF
Considering that ZBTB24 efficiently associates with PARP1-
generated PAR chains, we wondered whether ZBTB24 could be
involved in regulating the steady-state levels of such chains in
response to DNA damage. To examine this possibility, we
monitored global PAR levels by Western blot analysis in cells
exposed to IR. Although hardly any PARylation could be ob-
served in mock-treated cells, exposure to IR triggered robust
DNA damage-induced PARylation (Fig. 5, A and B), which was
largely suppressed (∼60–70%) by knockdown of PARP1 (Fig. 5, A
and B). Strikingly, knockdown of ZBTB24 also caused a signifi-
cant reduction (∼50%) in PARylation in IR-exposed cells (Fig. 5,
A and B), suggesting that ZBTB24 is required to boost the DNA
damage-induced PARylation response.
It is feasible that ZBTB24 regulates steady-state PAR levels by
either stimulating the synthesis of such chains or preventing
their degradation. To examine a potential stimulatory role for
ZBTB24 in PAR synthesis, we reconstituted PARP1-dependent
synthesis of PAR in an in vitro system in the absence or pres-
ence of recombinant ZBTB24 or ZBTB24 lacking its ZNF domain
(ZBTB24 ΔZNF; Fig. 5 C and Fig. S4 A). In the presence of NAD+
and a damaged DNA template, we found that the capacity of
recombinant PARP1 to synthesize PAR chains was slightly en-
hanced by the presence of recombinant ZBTB24, but not ZBTB24
ΔZNF (Fig. 5, D and E), suggesting that ZBTB24 may weakly
stimulate PARP1-dependent PAR synthesis in manner depen-
dent on its ZNF.
Another nonmutually exclusive possibility is that ZBTB24
binding to PAR chains protects such chains from efficient hy-
drolysis by the PARP1 antagonist PARG. To explore this possi-
bility, we allowed PARP1-dependent synthesis of PAR in our
in vitro system and, after the inactivation of PARP1 by PARPi,
added recombinant PARG hydrolase with increasing amounts of
recombinant ZBTB24 or ZBTB24 ΔZNF (Fig. 5 F). We could de-
tect efficient hydrolysis of nearly all PAR chains in the absence
of ZBTB24 or ZBTB24 ΔZNF (lane 1 versus 2; Fig. 5 G). Inter-
estingly, ZBT24 inhibited in a dose-dependent manner the
breakdown of PAR products in the hydrolysis reaction (Fig. 5, G
and H), whereas ZBTB24 ΔZNF was unable to do so, suggesting
that ZBTB24 binds PAR chains through its ZNF to protect them
from PARG-dependent degradation (Fig. 5, G and H). In con-
clusion, we found that ZBTB24 promotes the steady-state levels
of DNA damage-induced PAR chains by stimulating the PARP1-
dependent synthesis and inhibiting the PARG-dependent hy-
drolysis of such chains.
ZBTB24 and PARP1 promote c-NHEJ by regulating XRCC4/LIG4
assembly
We then sought to address how ZBTB24’s role in PAR synthesis and
protection is linked to its involvement in c-NHEJ (Fig. 2 and Fig. S2,
C–E). Interestingly, in vitro studies demonstrated that the c-NHEJ
ligase LIG4 interacts with PAR chains through its C-terminal
BRCT domain (Li et al., 2013), providing a possible link be-
tween ZBTB24’s involvement in PAR stability and NHEJ. To
study this further, we first applied laser microirradiation to
monitor the recruitment of GFP-XRCC4 to damaged DNA in
U2OS cells that were either treated with PARPi or depleted for
PARP1. In line with previously published work (Luijsterburg
et al., 2016), the loss of both PARP activity and PARP1 protein
markedly impaired the recruitment of GFP-XRCC4 (Fig. S4,
B–E), suggesting that PARP1-dependent PARylation regulates
the assembly of XRCC4/LIG4 complexes at sites of DNA
damage to promote c-NHEJ. To confirm this, we used the
plasmid integration assay to specifically examine PARP1’s
contribution to c-NHEJ. In agreement with our recruitment
data and previous findings (Luijsterburg et al., 2016), we
found that PARP1 depletion resulted in a ∼40% reduction in
c-NHEJ efficiency (Fig. S2 F and Fig. 4 F), suggesting that
PARP1, similar to ZBTB24 (Fig. 2, E and F), promotes c-NHEJ.
Given ZBTB24’s role in NHEJ, its interaction with PARP1 and
its stimulatory effect on PARylation, we addressed whether
ZBTB24 affects the PARP1-dependent assembly of XRCC4/LIG4
at DSBs. Depletion of ZBTB24, similar to that of PARP1, resulted
in a strong reduction in GFP-XRCC4 recruitment at sites of laser-
induced DNA damage (Fig. 6, A and B). Moreover, ZBTB24 de-
pletion also reduced the accumulation of endogenous XRCC4,
whereas DNA damage levels measured by γH2AX remained
unaffected (Fig. S4, G–I). Importantly, the accumulation of GFP-
XRCC4 at a stably integrated lactose operator (LacO) array upon
tethering of a lactose repressor (LacR)–tagged FokI nuclease in
U2OS cells was also strongly reduced in cells depleted for
ZBTB24 (Fig. 6, C–F). This indicates that ZBTB24 acts at bona
fide DSBs to facilitate the accumulation of functional XRCC4/
LIG4 complexes.
Finally, we showed that ZBTB24’s ZNF domain is important
for the PARP1 activity-dependent recruitment of ZBTB24 to
DSBs (Fig. 4 and Fig. S3, I–N). Based on this and the fact that
ZBTB24 promotes XRCC4/LIG4 accrual at DSBs, we hypothe-
sized that ZBTB24’s ZNF may play an important role in this
process. To examine this, we generated HeLa Flp-In/T-REx cells
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Figure 5. ZBTB24 stimulates PARP1-dependent PAR synthesis and protects PAR chain stability. (A) U2OS cells transfected with the indicated siRNAs
were left untreated or exposed to IR. 5 min later, whole-cell extracts (WCEs) were prepared and subjected to Western blot analysis for DNA-PKcs and PAR.
DNA-PKcs is a loading control. (B) Quantification of the results from A and a second independent experiment. The mean ± SEM is shown. The ratio of PAR/
loading control signals per sample was normalized to that of the IR-exposed siLuc sample, which was set to 1. Statistical significance was calculated using
Student’s t test (*, P < 0.05; **, P < 0.01). (C) Schematic of the PAR synthesis assay. (D) Recombinant PARP1 was incubated with a damaged DNA template and
activated by NAD+ in the presence of increasing concentrations of GST-ZBTB24, GST-ZBTB24 ΔZNF, or GST only. The presence of 10H-PAR chains and
recombinant proteins was monitored by Western blot analysis. (E) Quantification of ZBTB24-dependent stimulation of PAR synthesis from D and two other
independent experiments. The mean ± SD is shown. The signal of 10H-PAR for each sample containing GST-ZBTB24 or GST-ZBTB24 ΔZNF was normalized to
that without GST-ZBTB24, which was set to 1. Statistical significance was calculated using Student’s t test (*, P < 0.05). (F) Schematic of the PAR protection
assay. (G) Recombinant PARP1 was incubated with a damaged DNA template and activated by NAD+ to generate PARylated PARP1. Increasing concentrations
of GST-ZBTB24, GST-ZBTB24 ΔZNF, or GST alone were added, followed by incubation with PARG. The presence of 10H-PAR chains and recombinant proteins
was monitored by Western blot analysis. (H) As in E, except that PAR protection was measured from G and another independent experiment. The mean ± SD is
shown. Statistical significance was calculated using Student’s t test (*, P < 0.05).
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Figure 6. ZBTB24 promotes XRCC4/LIG4 assembly at DNA damage sites. (A) U2OS stably expressing GFP-XRCC4 were transfected with the indicated
siRNAs and subjected to laser microirradiation. Representative images of unirradiated and irradiated cells (taken at the indicated time point after irradiation)
are shown. Scale bar, 10 µm. (B) Quantification of A. The mean ± SEM of three independent experiments is shown. Statistical significance was calculated using
Student’s t test (****, P < 0.0001). (C) Schematic of the system in U2OS 2-6-3 cells used to locally induce multiple DSBs upon tethering of the FokI endo-
nuclease. (D) Accumulation of XRCC4 (green) to γH2AX-marked (white) DSBs induced by FokI-mCherry-LacR at a LacO array (red) in cells transfected with the
indicated siRNAs. Scale bar, 10 µm. (E) Quantification of XRCC4 accumulation in D. The mean ± SD of two independent experiments is shown. Statistical
significance was calculated using Student’s t test (*, P < 0.05; **, P < 0.01). (F) As in E, except for γH2AX. The mean ± SD of two independent experiments is
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stably expressing inducible and siRNA-resistant GFP-tagged
ZBTB24 or ZBTB24 ΔZNF (Fig. S5, A and B). Confirming our
previous data (Fig. 4 C and Fig. S3, K–L), we found that GFP-
ZBTB24 was recruited to laser-induced DNA damage tracks,
whereas GFP-ZBTB24 ΔZNF failed to do so after expression in
ZBTB24-depleted cells (Fig. S5, C and D). Importantly, the ex-
pression of GFP-ZBTB24, but not that of GFP-ZBTB24 ΔZNF,
rescued the reduced XRCC4 accumulation in ZBTB24 knock-
down cells (Fig. 6, G and H), whereas γH2AX signals remained
unaffected (Fig. S5 E). This indicated that the NHEJ defects ob-
served in ZBTB24-depleted cells were not due to off-target ef-
fects of the siRNAs (Figs. 2 and 6). Moreover, these results show
that the ZNF in ZBTB24 plays a critical role in regulating the
PARP1 activity-dependent assembly of XRCC4/LIG4 at DNA
breaks that undergo c-NHEJ.
ZBTB24-deficient cells show a-NHEJ signatures at repair
junctions and impaired CSR
ICF2 patients with loss of ZBTB24 suffer from immunodefi-
ciency characterized by defective CSR (Fig. 1). At the molecular
level, we found that CSR junctions in B cells from ICF2 patients
show an altered repair pattern with a decrease in direct end-
joining and an increased usage of long microhomologies, sug-
gesting a shift from the use of c-NHEJ to the use of a-NHEJ
similar to that observed in B cells from LIG4- and Artemis-
deficient patients (Table 1, Data S1, Data S2, and Data S3). To
corroborate these findings, we examined mutational signatures
at repair junctions in the GC92-NHEJ reporter (Taty-Taty et al.,
2016), in which we observed that loss of ZBTB24 impairs NHEJ
(Fig. S2, C–E). Interestingly, compared with control cells,
ZBTB24 depletion increased the proportion of larger deletions and
use ofmicrohomology during repair (Fig. 7, A–C) to a similar extent
as observed after KU80 knockdown (Fig. 7, A–C; Kabotyanski et al.,
1998). These repair features in ZBTB24-depleted cells were remi-
niscent of those observed at CSR junctions in B cells from ICF2
patients (Table 1).
To determine whether ZBTB24 is involved in CSR, we in-
activated the Zbtb24 gene using CRISPR/Cas9-based genome
editing in CH12 cells, a murine B cell line that can be induced to
express AID and undergo CSR from IgM to IgA in vitro. We
obtained one Zbtb24+/− and two Zbtb24−/− CH12 B cell clones
(Fig. 7 D). Upon CSR induction, we found that the Zbtb24−/−
clones displayed defective CSR compared with Zbtb24+/+ or
Zbtb24+/− controls (Fig. 7, E and F). Importantly, the observed
CSR defect was independent of defects in AID expression
(Fig. 7 D). To rule out potential off-target effects of Cas9-based
genome editing and to demonstrate that the CSR defect observed
in Zbtb24−/− cells is due to the absence of Zbtb24, we reex-
pressed mouse Zbtb24 cDNA in these cells (Fig. 7 G). We found
that overexpression of mZbtb24 rescued the CSR defect in
Zbtb24−/− cells (Fig. 7, H and I), demonstrating that the loss of
Zbtb24 caused the CSR defect. Taken together, these findings
show that ZBTB24 is involved in c-NHEJ during CSR, providing a
molecular basis for the immunodeficiency in ZBTB24-deficient
ICF2 patients.
Discussion
Mutations in at least four different genes cause the primary
immunodeficiency ICF. Approximately 30% of the ICF patients
carry causal mutations in the uncharacterized ZBTB24 gene
(ICF2; Thijssen et al., 2015; Weemaes et al., 2013). Here, we
functionally characterized the role of ZBTB24 in relation to
the immunodeficiency by biochemical and cell biological ap-
proaches, as well as by functional analysis in patient-derived
material. In ICF2 patients, we observed a severe reduction in
Ig production and diversification capacity, and a shift toward
a-NHEJ events during CSR characterized by larger deletions
and more microhomology use in the switch junctions, which
is reminiscent of the phenotype observed in cells from
c-NHEJ–deficient patients (Du et al., 2008; Pan-Hammarstro¨m
et al., 2005). Indeed, recent work suggested that in the absence
of the KU70/80 complex, Rad52 binds to DSB ends within S
regions to modulate CSR by a microhomology-mediated a-NHEJ
process (Zan et al., 2017). Our findings provide a plausible
molecular explanation for the currently unexplained immu-
nodeficiency in ICF2 and suggest a role for ZBTB24 in c-NHEJ.
Indeed, we reveal that ZBTB24 is recruited to sites of DNA
damage in a PARP1-dependent manner by associating with
PARP1-generated PAR-chains through its ZNF domain. Our
biochemical and cellular analyses show that ZBTB24 promotes
PARP1-mediated PAR synthesis and acts as a scaffold protein
that protects PAR chains from degradation, thereby enhancing
the PARP1-dependent recruitment of the LIG4/XRCC4 complex
to facilitate efficient DSB repair by c-NHEJ (see model; Fig. 7 J).
Consequently, ZBTB24 loss shifts DSB repair from LIG4/
XRCC4-dependent c-NHEJ to a-NHEJ, consistent with the CSR
phenotype observed in ICF2 patients (Fig. 7 K).
ZBTB24 is required for CSR, a process defective in
ICF2 patients
Mutations in ZBTB24 lead to defective CSR in ICF2 patients,
whereas V(D)J recombination remains unaffected. This may be
unexpected, considering that both processes heavily rely on
c-NHEJ. However, mutations in several other DNA damage re-
sponse (DDR) genes, such as H2AX, NIPBL, and ATM in both
mice and humans, cause a remarkably similar defect in CSR
without affecting V(D)J recombination (Enervald et al., 2013;
Manis et al., 2004; Pan et al., 2002; Reina-San-Martin et al.,
2003). It has been suggested that the ends of recombination-
shown. Statistical significance was calculated using Student’s t test (ns, not significant). (G) Accumulation of endogenous XRCC4 (white) and γH2AX (orange) in
laser microirradiated HeLa Flp-In/T-REx cells expressing doxycycline (dox)-inducible GFP-ZBTB24 or GFP-ZBTB24 ΔZNF after transfection with the indicated
siRNAs. Cells were fixed and immunostained 10 min after laser microirradiation. Scale bar, 10 µm. (H) Quantification of endogenous XRCC4 levels in laser
tracks from G. The mean ± SEM of two to three independent experiments is shown. Statistical significance was calculated using Student’s t test (*, P < 0.05; **,
P < 0.01; ****, P < 0.0001; ns, not significant).
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Figure 7. ZBTB24-defiecent cells show a-NHEJ signatures at repair junctions. (A–C) Mutational signatures (A), deletion sizes (B), and microhomology
usage (in case of deletion formation; C) at repair junctions in the GC92 reporter for NHEJ. GC92 cells were transfected with the indicated siRNAs and I-SceI
expression vector. Repair junctions were amplified by PCR and Sanger sequenced. The bars represent data obtained from three independent experiments.
(D)Western blot analysis of Zbtb24 and AID expression in wild-type CH12 cells (Zbtb24+/+), Zbtb24+/−, and Zbtb24−/− clones stimulated to undergo CSR for 3 d
with TGF-β, IL-4, and an anti-CD40 antibody. β-Actin is a loading control. (E) Flow cytometry analysis of cells from D. The percentage of IgA-expressing cells is
indicated. Representative contour plots of three independent experiments are shown. (F) Quantification of cells from E. The mean ± SD from three
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activating gene 1/2 (RAG1/2)–induced DSBs are held together by
these enzymes during V(D)J recombination. In contrast, AID-
initiated DSBs during CSR are likely held together by factors
involved in the signaling of DSB, such as the core chromatin
component H2AX and 53BP1 (Manis et al., 2004; Petersen et al.,
2001). The role of ZBTB24 may resemble that of the latter DDR
components, explaining its specific impact on CSR. Alterna-
tively, RAG1/2 induces DSBs that are characterized by the pro-
duction of a hairpin structure at the broken ends. PARP1
swiftly binds to single-strand breaks and DSBs (Eustermann
et al., 2011; Langelier et al., 2012), as well as to hairpin
structures in vitro (Lonskaya et al., 2005). However, whether
it also displays affinity for RAG1/2-induced hairpin structures
at DSBs in vivo remains to be determined. It is conceivable
that these structures are not bound by PARP1 owing to their
processing by the structure-specific endonuclease Artemis
(Alt et al., 2013), which could rule out a function for PARP1
and most likely ZBTB24 in V(D)J recombination and would be
in agreement with our observations. However, PARP1 is ac-
tivated by and seems to have affinity for AID-induced breaks
in mice, where it promotes CSR through a-NHEJ (Robert et al.,
2009). Whether it also modulates CSR in humans remains
elusive, mainly because patients with loss-of-function muta-
tions in PARP1 have not been reported yet.
Neither ICF2 patient-derived fibroblast cells nor ZBTB24 KO
U2OS cells displayed hypersensitivity to IR-induced DNA
breaks, suggesting a cell type– and/or context-specific role for
ZBTB24 in NHEJ. It was reported that ZBTB24 KO HEK293 cells,
which showed reduced CDCA7 expression, were also not sensi-
tive to DNA-damaging agents (Unoki et al., 2019). Additionally,
the ZBTB24 KO HEK293 cells displayed a reduced proliferation
capacity, but this phenotype could not be rescued by re-
expression of ZBTB24, suggesting that irreversible changes have
occurred in these KO cells. Such adaptive changes may have also
occurred in our ICF2 patient-derived fibroblast and ZBTB24 KO
U2OS cells, possibly explaining the lack of a NHEJ phenotype.
Consequently, NHEJ defects may “only” be observed after short-
term depletion of ZBTB24 in B cells from ICF2 patients or in
differentiated human cells. Interestingly, like ICF2, ICF3 and
ICF4 patients also suffer from immunodeficiencies associated
with hypo- or agammaglobulinemia in the presence of B cells.
Moreover, recent work has implied a role for CDCA7 (ICF3) and
HELLS (ICF4) in NHEJ (Unoki et al., 2019), although it is unclear
whether these ICF proteins participate in the PARP1/ZBTB24-
dependent pathway that drives c-NHEJ. These findings may
suggest that defects in this process may be a more general
phenomenon associated with ICF syndrome, specifically with
regard to the observed immunodeficiency.
ICF syndrome is associated with defects in DNA methylation
manifested by hypomethylation of pericentromeric satellite re-
peats (Vukic and Daxinger, 2019). Thus, besides its direct role
in c-NHEJ, ZBTB24 may also regulate CSR indirectly as an epi-
genetic modifier. ZBTB24 regulates genome-wide DNMT1-
dependent DNA methylation, which has been shown to alter
transcription programs (Vukic and Daxinger, 2019; Wu et al.,
2016). This could potentially affect the expression of genes in-
volved in B cell development and the transcriptional status of
CSR machinery (Lee and Maeda, 2012). However, we observed
normal naive B cell counts, as well as normal AID and germline
transcript levels, within the Cα part of the IGH locus in B cells
from ICF2 patients, suggesting that these cells develop normally
and can properly initiate CSR. Thus, although we cannot com-
pletely rule out epigenetic effects on the immunodeficiency in
ICF2, the low switched B cell numbers and impaired production
of Igs likely arises from defects in completing the CSR process,
i.e., in the c-NHEJ–dependent repair of AID-induced DSBs.
ZBTB24 and PARP1 in NHEJ
The current models for NHEJ distinguish a dominant c-NHEJ
pathway that is fully dependent on KU70/KU80 from a PARP1-
dependent a-NHEJ pathway that becomes active only in the
absence of KU70/KU80 (Wang et al., 2006). However, although
PARP1 is required for a-NHEJ, this does not exclude a stimula-
tory role for PARP1 in c-NHEJ. Indeed, several studies reported
that the loss of PARP1 activity modulates the c-NHEJ–dependent
rejoining of DSBs in hamster, mouse, and human cells
(Luijsterburg et al., 2016; Mitchell et al., 2009; Veuger et al.,
2003). Our results corroborate and extend these observations
and further support a role for PARP1 in DSB repair through
c-NHEJ. However, the c-NHEJ–specific phenotypes, such as
impaired random plasmid integration or XRCC4 recruitment to
laser/nuclease-induced DSBs (which we observed after
knockdown of ZBTB24 or PARP1), were not as strong as seen
after depletion of core NHEJ factors, such as DNA-PKcs. This
suggests that the PARP1-ZBTB24 axis is not essential for c-NHEJ
but stimulates this process in human cells. Moreover, loss of
ZBTB24 reduces NHEJ in the EJ5-GFP reporter. Because this
reporter cannot discriminate between c-NHEJ and a-NHEJ, we
cannot rule out the possibility that ZBTB24 might promote both
c-NHEJ and a-NHEJ. An involvement in the latter repair path-
way would not be surprising given its interaction with PARP1,
which is required for a-NHEJ (Pines et al., 2013).
independent experiments is shown. Data were normalized to wild-type Zbtb24+/+ cells, which were set to 100%. Statistical significance was calculated using
Student’s t test (***, P < 0.001; ****, P < 0.0001; ns, not significant). (G)Western blot analysis of Zbtb24 and AID expression in Zbtb24−/− clones transduced
with an empty retrovirus (pMX-PIE) or a retrovirus expressing mZbtbt24 and EGFP cDNA (pMX-mZtbtb24) and stimulated to undergo CSR for 3 d with TGF-β,
IL-4, and an anti-CD40 antibody. β-Actin is a loading control. (H) Flow cytometry analysis of cells from G. Dot plots are gated on EGFP+ cells. The percentage of
IgA-expressing cells is indicated. Representative contour plots of two independent experiments are shown. (I) Quantification of cells from H. The mean ± SD
from two independent experiments is shown. Data were normalized to uninfected wild-type Zbtb24+/+ cells, which were set to 100%. –, not infected. Sta-
tistical significance was calculated using one-way ANOVA (*, P < 0.05; ***, P < 0.001). (J) Model for the role of ZBTB24 in DSB repair by NHEJ. ZBTB24
accumulates at DSBs, where it functions as a scaffold to protect PARP1-associated PAR-chains, which serve as a docking site for the LIG4-XRCC4 complex,
facilitating efficient repair of DSBs via c-NHEJ. (K) Schematic illustrating that ZBTB24 loss leads to a shift from c-NHEJ to a-NHEJ and impaired CSR at AID-
induced DSBs in B cells.
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The C2H2 ZNF of ZBTB24 binds PAR chains
Four structurally distinct protein motifs have been character-
ized to mediate interactions with PAR chains: (1) a consensus of
eighth interspersed basic and hydrophobic amino acid residues;
(2) macro domains containing a conserved ligand-binding
pocket; (3) the WWE domain that recognizes iso-ADP-ribose,
which is the smallest internal structural unit of PAR; and (4) the
PAR-binding zinc (PBZ) finger (Kalisch et al., 2012). Here we
expand the latter category by showing that the C2H2 ZNF, as
present in ZBTB24, is a new type of motif that mediates PAR
binding. Although this motif has been suggested to predomi-
nantly bind to DNA (Najafabadi et al., 2015), we demonstrate
that the eight C2H2 ZNFs within ZBTB24 associate with PAR
chains in vitro and mediate the interaction with PARP1 in vivo.
Interestingly, a recent screen for DDR factors identified >100
new proteins, many of which were ZNF-containing transcrip-
tion factors that, similar to ZBTB24, were recruited to sites of
laser-induced DNA damage in a PARP/PARylation-dependent
manner (Izhar et al., 2015). Further studies on these DNA
damage–associated ZNF-containing proteins may reveal
whether they have evolved as general PAR-binding proteins
with specialized functions in the PARP-dependent DDRs. Al-
ternatively, part of the ZNF domain in ZBTB24 has been shown
to confer specificity of DNA binding (Ren et al., 2019). Thus, we
cannot rule out the possibility that both PAR and DNA binding
are critical determinants of ZBTB24’s function during the
PARP-dependent DDR.
ZBTB24 stimulates PAR synthesis and protects PAR chains
Based on its functional domains, ZBTB24 seems to lack enzy-
matic activity. Indeed, our work suggests that ZBTB24 has at
least two noncatalytic roles: (1) it can enhance PAR synthesis by
PARP1 and (2) it can bind and protect PAR chains from hy-
drolysis by PARG. How does ZBTB24 stimulate PAR synthesis by
PARP1? Twomodels exist for the activation of human PARP1: the
cis and trans models. In the cis model, a single PARP1 protein
binds a DNA end, which triggers intramolecular interactions and
conformational changes that enhance the flexibility of the cat-
alytic domain to induce auto-PARylation (Langelier et al., 2012).
One possibility is that ZBTB24, by binding to PARP1, stimulates
these intramolecular interactions and conformational changes,
resulting in enhanced PARP1 activation. Alternatively, in the
trans model, two PARP1 proteins dimerize at a DSB, subse-
quently enabling one of these PARP1 molecules to modify the
catalytic domain of its interaction partner (Ali et al., 2012). BTB
domains, such as those found in ZBTB24, are known to mediate
dimerization between proteins (Bardwell and Treisman, 1994). It
is therefore possible that ZBTB24’s interaction with PARP1 and
its ability to dimerize could stimulate PARP1 dimerization and
its subsequent activation. Additional biochemical work will be
required to reveal whether ZBTB24 promotes in cis and/or in
trans activation of PARP1.
In contrast to ZBTB24’s role in PARP1 activation, its contri-
bution to PAR protection may be easier to explain. We demon-
strated that ZBTB24, through its ZNF domain, directly associates
with PARP1-associated PAR chains. This may sterically hinder
PARG from attacking PAR chains. However, some PAR chains
are digested despite the presence of excess ZBTB24 (Fig. 5, G and
H), which could be due to the highly versatile endo- and exo-
glycosidic activities of PARG toward PAR (Brochu et al., 1994). It
may be that additional PAR-binding factors are required to
provide full protection against PARG hydrolysis. These factors
may for instance include one or more ZNF-containing tran-
scription factors or DDR proteins with intrinsically disordered
domains that are recruited to sites of DNA damage in a PAR-
dependent manner (Altmeyer et al., 2015; Izhar et al., 2015).
We observed that at concentrations up to two times that of
PARP1, ZBTB24 can only activate PARP1, whereas at more than
two times the concentration of PARP1, it protects PAR chains
rather than that it helps to activate PARP1 (Fig. 5, D, E, G, and H).
This suggests that ZBTB24may switch function depending on its
concentration relative to PARP1. Based on this, at sites of DNA
damage, we envision a scenario in which ZBTB24, after its initial
recruitment, helps with the activation of PARP1 and subse-
quently protects the synthesized PARP1-associated PAR chains.
As such it could facilitate the PARylation-dependent interaction
between the c-NHEJ ligase LIG4 and PARP1, whichmay either be
direct through interaction of the C-terminal BRCT domain of
LIG4 with PAR (Li et al., 2013), or indirect through one of known
PAR-binding proteins that helps to recruit the XRCC4/LIG4
complex (Ray Chaudhuri and Nussenzweig, 2017; Teloni and
Altmeyer, 2016) to promote DSB repair by c-NHEJ (Fig. 7 J).
Materials and methods
Patients
Sera and PBMCs were obtained from four ICF2 patients: p49 and
p55 (Weemaes et al., 2013), p67 (Rf1225), and p71 (Rf1461; (van
den Boogaard et al., 2017). p49, p67, and p71 carry the same re-
cessive mutation (Table S1). ICF2 fibroblasts were from p71. A
statement of no objection for the use of anonymized patient
material was obtained from the medical review ethics commit-
tee of the Leiden University Medical Center. All ICF2 patient and
control material was used after informed consent.
Isolation of PBMCs and phenotyping of lymphocytes
PBMCswere obtained from patients and healthy donors by Ficoll
density gradient separation. PBMCs were stored in liquid ni-
trogen until analysis. Thawed PBMCs were stained with the
following fluorochrome-labeled antibodies against the indicated
cell surface antigen: CD3 (clone UCHT1) and CD4 (13B8.2;
Beckman-Coulter); CD8 (SK1), CD19 (SJ25C1), CD20 (L27), CD27
(L128), CD28 (L293), and IgM (G20-127; BD Biosciences); CCR7
(150503; R&D Systems); IgD (rabbit F(ab9)2; Dako); CD45RA
(MEM-56; Invitrogen Life Technologies). DAPI was added to
discriminate between live and dead cells. Samples were ana-
lyzed on a BD Biosciences LSR II flow cytometer with DIVA
software.
In vitro B cell stimulation and analysis of IgG and
IgA production
PBMCs (0.25 × 106/well) were cultured in a flat-bottom 96-well
plate in AIM-V medium supplemented with 5% FCS ultra-low
IgG, penicillin/streptomycin (100 IU/ml and 100 µg/ml; Life
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Technologies), 0.05 mg/ml transferrin (BioChemika), and 5 µg/
ml insulin (Sigma-Aldrich). Added stimuli were MAB89 (aCD40;
0.5 µg/ml; Beckman-Coulter), aIgM (1 µg/ml; Jackson Im-
munoresearch), CpG (ODN2006; 1 µg/ml; InvivoGen), and IL-21
(20 ng/ml; Peprotech). Supernatants were harvested at day 7 and
analyzed for IgG and IgA levels by sandwich ELISA using goat
anti-human IgG or IgA (Life Technologies) for coating of the 96-
well microtiter plates and alkaline phosphatase–conjugated goat
anti-human IgG or IgA (Life Technologies) for detection.
In vitro naive B cell stimulation and analysis of class switching
Naive B cells were magnetically sorted from PBMCs by negative
selection using the Naive B cell Isolation Kit II (Miltenyi). The
purity of sorted naive B cells was >95% as assessed by flow cy-
tometry (CD19+CD27−). Because of the sorting limitation of the
kit, the sorted cells contained small CD27−IgG+ (0.2–3.5%) or
CD27−IgA+ (0–0.8%) populations. The sorted cells were stimu-
lated with CD40 ligand (MEGACD40L; 100 ng/ml; Enzo), IL-21
(100 ng/ml), IL-10 (50 ng/ml; Peprotech), and anti-IgM (10 µg/
ml). For analysis of IgA and IgG production, an anti-IgM con-
centration of 1–10 µg/ml (10 ug/ml for flow cytometry and RNA
analysis, 1 µg/ml for ELISA) was used. The cells were cultured
for 6–10 d in round-bottom 96-well plates (5–10 × 104/well) in
RPMI 1640 supplemented with 10% FCS, penicillin/streptomy-
cin, 50 µM β-mercaptoethanol, 2.5 µg/ml transferrin (Bio-
Chemika), 1 µg/ml insulin, and nonessential amino acids
(Gibco). After 6 d, class switching of the stimulated cells was
analyzed by flow cytometry with antibodies against CD19
(Beckman Coulter), IgG (BD Biosciences), and IgA (Miltenyi).
DAPI was added to discriminate between live and dead cells.
Samples were analyzed on a BD Biosciences Canto II flow cy-
tometer with DIVA software. On day 6, RNA samples were ex-
tracted from the cultured cells (RNeasy Micro Kit; Qiagen) and
subjected to reverse transcription with SuperScript II Reverse
Transcription (Invitrogen). On day 10, supernatants were col-
lected, and IgG and IgA levels were analyzed by ELISA as
described above.
Expression of AID by real-time quantitative RT-PCR (RT-qPCR)
AID expression in sorted naive B cells was performed as de-
scribed previously (Cagigi et al., 2009). Briefly, RNA was iso-
lated from unstimulated and stimulated naive B cells after 6 d of
culture using the RNeasy Micro Kit (Qiagen) and subjected to
reverse transcription with SuperScript II Reverse transcription
(Invitrogen). 2× GoTaq qPCR Master Mix (Promega) was used
together with the previously described primers for amplification
of AID transcripts (Cagigi et al., 2009). AID expression was
normalized to the housekeeping gene GUSB (Table S5).
Amplification of Iα-Cα germline transcripts
Iα-Cα germline transcripts were assessed as described previ-
ously (Lin et al., 2014). Briefly, RNA was isolated from un-
stimulated and stimulated sorted naive B cells after 6 d of culture
using the RNeasy Micro Kit (Qiagen) and subjected to reverse
transcription with SuperScript II Reverse transcriptase (In-
vitrogen). KAPA HiFi HotStart ReadyMix (Roche) together
with previously described Iα-consensus, Cα1-specific, and Cα2-
specific primers (Lin et al., 2014) were used to amplify the
Iα1–Cα1 and Iα2–Cα2 germline transcripts. PCR amplification
was performed using 40 cycles at 95°C for 30 s, 68°C for 30 s,
and 72°C for 1 min.
Sequencing of switch recombination junctions
Amplification, cloning, and sequencing of the Sμ-Sα or Sμ-Sγ
fragments derived from PBMCs was performed using a previ-
ously described PCR strategy (Pan-Hammarstro¨m et al., 2005).
The CSR junctions were determined by aligning the switch
fragment sequences with the reference Sμ, Sα, or Sγ sequences.
Analysis of the repair pattern of the CSR junctions was per-
formed based on the suggested guidelines (Stavnezer et al.,
2010).
Ig heavy chain (IgH) repertoire analysis using next-generation
sequencing
The VH-JH rearrangements and Cα and Cγ transcripts were
amplified from post-Ficoll PBMCs in a multiplex PCR using the
VH1-6 FR1 and JH consensus BIOMED-2 primers (van Dongen et
al., 2003) or a consensus Cα (IGHA-R; 59-CTTTCGCTCCAGGTC
ACACTGAG-39) and Cγ primer (39Cγ-CH1; (Tiller et al., 2008).
The primers were adapted for 454 sequencing by adding the
forward A or reverse B adaptor, the TCAG key and multiplex
identifier (MID) adaptor. PCR products were purified by gel
extraction (Qiagen) and Agencourt AMPure XP beads (Beckman
Coulter). DNA concentration was measured using the Quant-it
Picogreen dsDNA assay (Invitrogen). Purified PCR products
were sequenced on the 454 GS junior instrument (Roche) ac-
cording to the manufacturer’s recommendations, using the GS
Junior Titanium emPCR (Lib-A), GS Junior Titanium sequencing,
and PicoTiterPlate kits for the VH-JH rearrangements, and
the GS Junior+ emPCR (Lib-A), GS Junior sequencing XL+, and
PicoTiterPlate kits for the Cα and Cγ transcripts. Using the IG-
Galaxy Tool (Moorhouse et al., 2014), sequences were demulti-
plexed based on theirMID sequence and quality checked. FASTA
files were uploaded in IMGT HighV-Quest (http://www.imgt.
org). Further analysis of the data was done using the IGGalaxy
tool. Uniqueness of sequences was defined by V, D, and J gene
usage and nucleotide sequence of the CDR3 region for the VH-JH
rearrangements, and V gene usage, amino acid sequence of the
CDR3 region, and C gene usage for the Cα and Cγ transcripts.
Only unique, productive sequences were used for the analysis,
and the frequency of mutated nucleotides in the VH gene was
calculated from CDR1 until FR3.
Cell culture
U2OS, HEK293, HEK293T, HeLa Flp-In/T-Rex, VH10-SV40-im-
mortalized fibroblasts, and SV40 T-transformed GM639 human
fibroblasts were grown in DMEM (Gibco) containing 10% FCS
(Bodinco BV) and 1% penicillin/streptomycin unless stated oth-
erwise, whereas CH12 cells were grown in RPMI 1640 (Gibco)
supplemented with 10% FCS. U2OS 2-6-3 cells containing 200
copies of a LacO-containing cassette (∼4 Mbp) were gifts from
Dr. J. Lukas (University of Copenhagen, Copenhagen, Denmark)
and Dr. S. Janicki (The Wistar Institute, Philadelphia, PA; Doil
et al., 2009; Shanbhag et al., 2010) and were used to establish
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U2OS 2-6-3 cell lines stably expressing GFP-tagged XRCC4.
Single U2OS clones stably expressing GFP-XRCC4 were isolated
after selection on puromycin (1 mg/ml). Immunoblotting with
anti-GFP antibody showed that the XRCC4 fusion proteins were
expressed at the expected molecular weight. U2OS 2-6-3 cells
stably expressing ER-mCherry-LacR-FokI-DD, which were a
gift from Dr. R. Greenberg (University of Pennsylvania, Phila-
dephia, PA; Tang et al., 2013), were induced for 5 h by 1 µM
Shield-1 (Clontech) and 1 µM 4-OHT (Sigma-Aldrich). SV40
T-transformed GM639 human fibroblasts with a stably inte-
grated GC92 reporter (GC92 cells) were a gift from Bernard
Lopez (Universite´ de Paris, Paris, France; Taty-Taty et al., 2016)
and were used to study mutational signatures at repair junc-
tions. ZBTB24 KO U2OS cells were generated by transfection of
pSpCas9(BB)-2A-GFP (PX458; Addgene 48138) containing Cas9
and a gRNA against ZBTB24 (59-AGATCCTCTTGGCTGAAC
CA-39), which was cloned into the BbsI site. 48 h after
transfection, cells were sorted by flow cytometry for GFP
expression and seeded at low density, after which individual
clones were isolated. Knockout of ZBTB24 in U2OS cells was first
verified by Sanger sequencing and TIDE analysis (https://tide.nki.
nl). Clones harboring out-of-frame deletions were further verified
by Western blot analysis. HeLa Flp-In/T-REx cells, which were
generated using the Flp-In/T-REx system (Thermo Fisher Scien-
tific), were a gift of Geert Kops (University Medical Centre
Utrecht, Utrecht, Netherlands) and Stephen Taylor (Washington
University, St. Louis, MO). These cells were used to generate
stable cells expressing inducible and siZBTB24-8-resistant ver-
sions of GFP-ZBTB24 and GFP-ZBTB24 ΔZNF by cotransfection of
pCDNA5/FRT/TO-Puro plasmid encoding GFP-ZBTB24 siZBTB24-
8-res or GFP-ZBTB24 ΔZNF siZBTB24-8-res, together with pOG44
plasmid encoding the Flp recombinase. After selection on 1 µg/ml
puromycin, single clones were isolated and expanded. Stable HeLa
Flp-In/T-REx clones were incubated with 2 µg/ml doxycycline for
24 h to induce expression of cDNAs. Additionally, GFP-tagged
ZBTB24 ΔZNF expression was reduced to endogenous ZBTB24
levels by repeated washout during 146 h. To generate Zbtb24−/−
CH12 clones, cells were transfected by electroporation using the
Neon transfection System (Thermo Fisher Scientific) with a plas-
mid expressing a gRNA targeting the first exon ofmZbtb24 (59-AAG
CTGCCCACAAGGCTCCG-39) and coexpressing the high-fidelity
Cas9 nuclease (Kleinstiver et al., 2016) fused to EGFP. 24 h after
transfection, individual EGFP-positive cells were sorted in 96-well
plates and cultured for 10 d. Clones were then genotyped by PCR,
sequencing, and Western blot.
Plasmids
The full-length cDNA of human ZBTB24 was obtained by RT-
PCR and flanking restriction sites for conventional cloning
(BglII/SalI) were introduced using a nested PCR on the cDNA.
The obtained PCR product was subsequently cloned into pEGFP-
C1 and pEGFP-N1 (both Clontech) using the BglII and SalI
restriction sites. The GST-ZBTB24 expression vector was gen-
erated by cloning the ZBTB24 ORF from pEGFP-C1-ZBTB24 as a
BglII/EcoRI fragment into BamHI/EcoRI-digested pGEX-6p-3
(GE Healthcare). The Myc-ZBTB24 expression vector was ob-
tained by exchanging GFP, using the AgeI and BglII restriction
sites, for a single Myc tag (EQKLISEEDL) by oligo annealing in
the pEGFP-ZBTB24 construct. Deletion constructs were gener-
ated by amplifying the specified regions using internal primers
containing BglII (forward) or EcoRI (reverse) restriction sites
and subsequent exchange of the deletion fragments for the full-
length cDNA. pCDNA5/FRT/TO-Puro plasmids encoding GFP-
ZBTB24 siZBTB24-8-res or GFP-ZBTB24 ΔZNF siZBTB24-8-res
were generated by cloning GFP-ZBTB24 or GFP-ZBTB24 ΔZNF
fragments into pCDNA5/FRT/TO-Puro. The underlined muta-
tions 59-CGAAAAGAGCACCGAGCAA-39were introduced by PCR
to generate resistance against siZBT24-8: 59-UGAGAAAAGUAC
AGAACAA-39. All ZBTB24 expression constructs were verified
using Sanger sequencing. The murine Zbtb24 cDNA was am-
plified by PCR from a cDNA library prepared from CH12 cells
using standard techniques and cloned into the pMX-PIE plasmid
(Barreto et al., 2003) using BamHI and NotI restriction enzymes.
mCherry-PARGwt/cd were kindly provided byMichael Hendzel
(Ismail et al., 2012) and GFP-PARP1 was obtained from Valerie
Schreiber (Institut de Ge´ne´tique et de Biologie Mole´culaire et
Cellulaire, Illkirch, France; Mortusewicz et al., 2007). The
XRCC4 cDNA, a generous gift of P. Jeggo (School of Life
Sciences, East Sussex, UK; Girard et al., 2004), was inserted
into EGFP-C1-IRES-Puro.
Transfections, RNA interference, and retroviral transductions
siRNA and plasmid transfections were performed using Lipo-
fectamine RNAiMAX (Invitrogen), Lipofectamine 2000 (In-
vitrogen), and JetPEI (Polyplus Transfection), respectively,
according to the manufacturer’s instructions. siRNA sequences
are listed in Table S5. Cells were transfected twice with siRNAs
(40 or 80 nM) within 24 h and examined further 48 h after the
second transfection unless stated otherwise. PARP inhibitor
(KU-0058948) was a gift from Mark O’Connor (AstraZeneca,
Cambridge, UK) and was used at a concentration of 10 µM.
The DNA-PK inhibitor (NU7026; EMD Biosciences) was used
at a concentration of 10 µM. CH12 cells were transduced with
retroviral supernatants obtained by transfecting Bosc23 cells
with an empty retrovirus (pMX-PIE; Puromycin-IRES-EGFP) or
a retrovirus expressing mZtbtb24 and EGFP cDNA (pMX-
mZbtb24) as described previously (Barreto et al., 2003).
Transduced cells were then selected with puromycin (1 µg/
ml) for 10 d.
NHEJ reporter assays
HEK293 cell lines containing a stably integrated copy of the EJ5-
GFP reporter or SV40 T-transformed GM639 human fibroblasts
containing a stably integrated copy of the GC92 reporter were
used to measure the repair of I-SceI–induced DSBs or NHEJ
(Bennardo et al., 2008; Pierce et al., 1999; Taty-Taty et al., 2016).
Briefly, 48 h after siRNA transfection, cells were transfected
with the I-SceI expression vector pCBASce and an mCherry
expression vector. 48 h later, the fraction of GFP-positive cells or
CD4-FITC–positive cells among the mCherry-positive cells was
determined by FACS on a BD LSRII flow cytometer (BD Biosci-
ence) using FACSDiva software version 5.0.3. Quantifications
were performed using Flowing software 2.5.1 (by Perttu Terho
in collaboration with Turku Bioimaging).
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Analysis of repair junctions in the GC92 reporter
Sequence analysis of repair junctions in the GC92 reporter was
performed as described (Taty-Taty et al., 2016). Briefly, GC92-
containing fibroblasts (GC92 cells) were first transfected with
siRNAs and 48 h later with the I-SceI expression vector pCBASce
(Pierce et al., 1999). 48 h later, genomic DNAwas extracted using
phenol:chloroform:isoamyl alcohol (25:24:1 vol/vol; Invitrogen).
PCR was performed on the genomic DNA using the CMV1 (59-
TGGCCCGCCTGGCATTATGCC-39) and CD4int (59-GCTGCCCCA
GAATCTTCCTCT-39) primers to amplify repair junctions. PCR
products were cloned into pGEM-T easy vector (Promega).
Colony PCR was performed using M13 primers (M13 FW 59-GTA
AAACGACGGCCAGT-39 and M13 RV 59-CAGGAAACAGCTATG
AC-39) on individual bacterial colonies to amplify repair junc-
tions, which were subjected to Sanger sequencing using the M13
FW primer. Sequences were analyzed using a custom Sanger
sequence analyzer as described previously (Schimmel et al.,
2017).
Plasmid integration assay
Upon siRNA-mediated knockdown of the indicated genes, U2OS
cells were transfected with XhoI/BamHI-linearized pEGFP-C1
plasmid DNA. After overnight transfection, a fraction of the
cells was used to determine transfection efficiency, which was
measured by the amount of GFP-positive cells using the Array-
Scan high content analysis reader (Thermo Fisher Scientific)
with the target activation protocol. In parallel, cells were seeded
on 14-cm plates at a density of 10,000 and 2,000 cells per plate
for determination of the cloning efficiency with and without
G418 (0.5 mg/ml; Gibco) selection, respectively. After 10 d, cells
were washed in 0.9% NaCl and stained with methylene blue.
NHEJ efficiency was calculated as follows: (cloning efficiency
G418 selection)/[(cloning efficiency without selection) ×
(transfection efficiency)] and subsequently normalized to
the luciferase control.
CSR assay in CH12 cells
CH12 cells were cultured for 72 h in the presence of TGF-β (1 ng/
ml; R&D Systems Europe), IL-4 (5 ng/ml; Peprotech), and an
anti-CD40 antibody (200 ng/ml; eBioscience). Cells were then
stained with an anti-IgA-PE antibody (Southern Biotech) to as-
sess CSR efficiency by flow cytometry. Before analysis, DAPI was
added to discriminate dead cells. Samples were analyzed using
an LSR flow cytometer (BD Biosciences) and FlowJo software.
Cell survival assay
VH10-SV40 cells were transfected with siRNAs, trypsinized,
seeded at low density, and exposed to IR at indicated doses. 7 d
later, cells were washed with 0.9% NaCl and stained with
methylene blue. Colonies of >10 cells were counted, and relative
survival compared with the untreated sample was calculated.
Cell cycle profiling
For cell cycle analysis, cells were treated as described in the figure
legends and fixed in 70% ethanol, followed by DNA staining with
50 µg/ml propidium iodide in the presence of RNase A (0.1 mg/ml).
Cell sorting was performed on a BD LSRII flow cytometer (BD
Biosciences) using FACSDiva software (version 5.0.3; BD
Biosciences). Quantification was performed using Flowing
software 2.5.1.
RNA expression analysis by RT-qPCR and RNA sequencing
Gene expression analysis using RT-qPCR was performed as de-
scribed before (Helfricht et al., 2013). Briefly, RNA isolation was
done using the miRNeasy minikit (Qiagen), and subsequently
polydT-primed cDNA was generated using the RevertAid first
strand cDNA synthesis kit (Thermo Fisher Scientific) according
to the manufacturer’s instructions. RT-qPCR was performed in
duplicate on the CFX96/384 system using SYBR green master
mix (Bio-Rad). Primers, which are listed in Table S5, were de-
signed using Primer3Plus software (http://primer3plus.com).
Relative expression levels were obtained with the CFX manager
(version 3.0), correcting for primer efficiencies and using
GAPDH and GUSB as reference genes. For RNA sequencing, the
RNA 6000 Nano kit (Agilent Technologies) was used to confirm
RNA integrity before the RNA was subjected to poly(A) en-
richment. cDNA synthesis, library preparation, and sequencing
were performed using the Ion Total RNA-Seq kit v2, the Ion
PI Template OT2 200 Kit v3, and the Ion Sequencing 200 kit v3,
respectively, according to the manufacturer’s instructions
(Thermo Fisher Scientific). RNA was sequenced on an Ion Pro-
ton System at a depth of ∼20 million reads per sample, with a
median read length of 90 bp. Sequence files obtained in the bam
format were converted to fastq using the bam2fastq conversion
utility from the bedtools package. Reads were aligned to the
human genome build GRCh37 - Ensembl using Tophat2 (version
2.0.10). In a second alignment step, Bowtie2 (version 2–2.10)
was used in the local, very sensitive mode to align remaining
unaligned reads. HTSeq-Count (version 0.6.1) was used with
default settings to quantify gene expression. Finally, DESeq
(version 1.2.10) was used to generate a list of genes differentially
expressed between ZBTB24-depleted and control cells (Table
S2). The data have been deposited to the SRA database with the
accession number PRJNA556576.
Sample preparation and MS
For SILAC, U2OS cells were cultured for 14 d in light (L;
[12C6,14N2]lysine/[12C6,14N4]arginine) or heavy (H; [13C6,15N2]ly-
sine/[13C6,15N4]arginine) SILAC medium. SILAC-labeled cells
were transiently transfected with either GFP-PARP1 or GFP-
ZBTB24 (H) and an empty vector (L). Equal amounts of H and L
cells were lysed separately in EBC-150 buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 0.5% NP-40, and 1 mM EDTA) supple-
mented with protease and phosphatase inhibitor cocktails. The
lysed cell suspension was sonicated six times for 10 s on ice and
subsequently incubated with 500 U Benzonase for 1 h under
rotation. The NaCl concentration was increased to 300 mM, and
the cleared lysates were subjected to GFP IPwith GFP Trap beads
(Chromotek). The beads were then washed twice with EBC-300
buffer (50 mM Tris, pH 7.5, 300 mM NaCl, 0.5% NP-40, and
1 mM EDTA) and twice with 50 mM (NH4)2CO3 followed by
overnight digestion using 2.5 µg trypsin at 37°C under constant
shaking. Peptides of the H and L precipitates were mixed and
desalted using a Sep-Pak tC18 cartridge by washing with 0.1%
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acetic acid. Finally, peptides were eluted with 0.1% acetic acid/
60% acetonitrile and lyophilized. Samples were analyzed by
nanoscale liquid chromatography–MS/MS using an EASY-nLC
system (Proxeon) connected to a Q-Exactive Orbitrap (Thermo
Fisher Scientific). Peptides were separated in a 13-cm analytical
column with inner diameter of 75 µm, in-house packed with 1.8
µmC18 beads (Reprospher; Dr.Maisch). The gradient lengthwas
120 min with a flow rate of 200 nl/min. Data-dependent ac-
quisition was used with a top 10 method. Full-scan MS spectra
were acquired at a target value of 3 × 106 and a resolution of
70,000, and the higher-collisional dissociation tandem mass
spectra (MS/MS) were recorded at a target value of 105 and with
resolution of 17,500 with a normalized collision energy of 25%.
The precursor ion masses of scanned ions were dynamically
excluded from MS/MS analysis for 60 s. Ions with charge 1 and
>6 were excluded from triggering MS2 events (Hendriks et al.,
2014). Analysis of raw data was performed using MaxQuant
software version 1.4.1.2 (Cox and Mann, 2008). The data have
been deposited to the ProteomeXchange Consortium via the
PRIDE partner repository with the dataset identifier PXD014741.
Protein interaction studies
To study ZBTB24 interactions, cells expressing the indicated GFP
fusion proteins were lysed in 1 ml EBC buffer (50 mM Tris, pH
7.3, 150mMNaCl, 0.5%NP-40, and 2.5mMMgCl) supplemented
with protease and phosphatase inhibitor cocktails (Roche). Lysis
and protein extraction were enhanced by 6 × 10-s sonication in a
sonicator bath (Bioruptor UCD-20; Diagenode) followed by 1-h
incubation with 500 units benzonase (Novagen) on ice. Upon
centrifugation, cleared lysates were subjected to IP with GFP
Trap beads (Chromotek) for 1.5 h at 4°C top over top. Beads were
washed six times with cold EBC buffer and boiled in Laemmli
buffer, and interacting proteins were visualized using Western
blot analysis.
Western blot analysis
Protein extracts were generated by direct lysis of cells in 2×
Laemmli buffer and boiled for 10 min at 95°C. Proteins were size
separated using Novex 4–12% Bis-Tris mini gels (Invitrogen) or
4–12% Criterion XT Bis-Tris gels (Bio-Rad) in 1× MOPS buffer
(Invitrogen) and transferred to PVDF membranes, which were
blocked in 4%milk for ≥30min and incubated with the indicated
antibodies overnight. Several wash steps before and after 1-h
incubation with secondary antibodies rabbit-anti-700 and
mouse-anti-800 (Sigma-Aldrich) were executed. Protein bands
were visualized using the Odyssey infrared imaging system or
the C-Digit blot scanner (both Licor) according to the manu-
facturer’s instructions. Representative Western blot images of
two to five independent experiments are shown.
Laser microirradiation
Multiphoton laser microirradiation was performed with a Leica
SP5 confocal microscope equipped with an environmental
chamber set to 37°C and 5% CO2 as described (Helfricht et al.,
2013). Briefly, U20S or HeLa Flp-In/T-Rex cells were grown on
18-mm glass coverslips, andmediumwas replaced with colorless
DMEM or CO2-independent Leibovitz L15 medium, both
supplemented with 10% FCS and penicillin/streptomycin. Cells
were placed in a Chamlide TC-A live-cell imaging chamber
before imaging and were kept at 37°C. DSB-containing tracks
(1- or 1.5-µm width) were generated with a Mira modelocked
Ti:Sapphire laser (λ = 800 nm, pulselength = 200 fs, repetition
rate = 76 MHz, and output power = 80 mW). Typically, cells
were microirradiated with 1 iteration/pixel using LAS-AF
software. For live-cell imaging, confocal images were recorded
before and after laser irradiation at different time intervals. For
UV-A laser microirradiation, U2OS or HeLa Flp-In/T-Rex cells
were sensitized with 10 µM BrdU for 24 h, as described
(Helfricht et al., 2013). For microirradiation, the cells were
placed on the stage of a Leica DM IRBE wide-field microscope
stand (Leica) integrated with a pulsed nitrogen laser (Micro-
point Ablation Laser System; Photonic Instruments; 16 Hz, 364
nm), which was directly coupled to the epifluorescence path of
the microscope and focused through a Leica 40× HCX Plan Apo
1.25–0.75 oil-immersion objective. The laser output power was
set to 78 to generate strictly localized subnuclear DNA damage,
and images were taken before and after microirradiation at the
indicated time points or after immunofluorescent labeling us-
ing Andor IQ software.
Immunofluorescent labeling
Immunofluorescent labeling of γH2AX, XRCC4, and GFP was
performed as described previously (Helfricht et al., 2013).
Briefly, cells were grown on glass coverslips and treated as
indicated in the figure legends. Subsequently, cells were
washed with PBS, fixed with 4% formaldehyde for 15 min and
treated with 0.25% Triton X-100 in PBS for 5 min. Cells were
rinsed with PBS and equilibrated in WB (PBS containing 5 g
BSA/liter and 1.5 g glycine/liter) before immunostaining. De-
tection was done using goat anti-mouse or goat anti-rabbit IgG
coupled to Alexa Fluor 488, 555, or 647 (Invitrogen Molecular
probes). Samples were incubated with 0.1 µg/ml DAPI and
mounted in Polymount.
Microscopy analysis
Images of fixed samples were acquired on a Zeiss AxioImager
M2 or D2 wide-field fluorescence microscope equipped with
40×, 63×, and 100× Plan Apo (1.4-NA) oil-immersion objectives
(Zeiss) and an HXP 120 metal-halide lamp used for excitation.
Fluorescent probes were detected using the following filters:
DAPI (excitation filter, 350/50 nm; dichroic mirror, 400 nm;
emission filter, 460/50 nm), GFP/Alexa Fluor 488 (excitation
filter, 470/40 nm; dichroic mirror, 495 nm; emission filter, 525/
50 nm), mCherry (excitation filter, 560/40 nm; dichroic mirror,
585 nm; emission filter, 630/75 nm), Alexa Fluor 555 (excitation
filter, 545/25 nm; dichroic mirror, 565 nm; emission filter, 605/
70 nm), and Alexa Fluor 647 (excitation filter, 640/30 nm; di-
chroic mirror, 660 nm; emission filter, 690/50 nm). Images
recorded after multiphoton- and UV-A–laser microirradiation
and immunofluorescence stainings were analyzed using ImageJ
(National Institutes of Health). The average pixel intensity of
laser tracks induced by either the multiphoton- or the UV-A
laser system was measured within the locally irradiated area
(Idamage), in the nucleoplasm outside the locally irradiated area
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(Inucleoplasm), and in a region not containing cells in the same
field of view (Ibackground) using ImageJ. The relative level of
accumulation expressed relative to the protein level in the nu-
cleoplasm was calculated as [(Idamage − Ibackground)/(Inucleoplasm −
Ibackground) − 1]. The accumulation in the control cells transfected
with siLuc within each experiment was normalized to 100%.
Images obtained from live-cell imaging after multiphoton mi-
croirradiation were analyzed using LAS-AF software. Fluores-
cence intensities were subtracted by the prebleach values and
normalized to the first data point, which was set to 0, to obtain
relative fluorescence units. The average reflects the quantifica-
tion of between 50 and 150 cells from two to three independent
experiments.
Antibodies
Immunofluorescence, Western blot, and flow cytometry analysis
were performed using antibodies against GFP (1:1,000,
11814460001, Roche; or 1:1,000, ab290, Abcam), PARP1 (1:1,000,
9542, Cell Signaling, Alexis), Myc (1:1,000, 9E10, SC-40, Santa
Cruz), γH2AX (1:1,000, 07-164, Millipore), α-tubulin (Sigma-
Aldrich), DNA-PKcs (1:500, ab1832, Abcam), LIG4 (1:1,000,
80514, Abcam), XRCC4 (1:500, gift from Mauro Modesti, Mar-
seille Cancer Research Center, Marseille, France), histone H3 (1:
2,000, 1791, Abcam), GST (1:2,000, Amersham), PARP1 (1:1,000,
9542S, Cell Signaling), PARP2 (1:500, C3956, Sigma-Aldrich),
ZBTB24 (1:1,000, PM085, MBL), CDCA7 (1:250, ProteinTech),
RAD51 (1:2,000, sc-6862, Santa Cruz), CD4-FITC (1:100, 100509,
BioLegend), β-actin (1:2,000, AC15, Sigma-Aldrich), PAR
(1:1,000, 4336-BPC-100, Trevigen; used in Fig. 5, A and B), PAR
monoclonal 10H, which was purified from the culture medium
of 10H hybridoma obtained from Dr. Miwa (Nagahama Institute
of Bio-Science and Technology, Nagahama, Japan) through the
Riken cell ban (Kawamitsu et al., 1984), and custom-made
monoclonal AID (Jeevan-Raj et al., 2011).
GST protein purification
For GST purification, 50-ml cultures of Escherichia coli BL21 cells
containing pGEX-6p-3 or pGEX-6p-3-ZBTB24 plasmid were
grown to an OD600 of 0.6 absorbance units. 2 mM IPTG was
added, and cells were incubated overnight at 20°C. After cen-
trifugation, cell pellets were frozen and stored at −80°C. For
protein purification, cell pellets were lysed at room temperature
for 30 min in 2.5 ml lysis buffer (125 mM Tris-HCl, pH 8,
150 mM NaCl, 1 mM MgCl2, 5 mM DTT, 0.1 volume BugBuster
10× [Novagen-Merck], 2,500 units rLysozyme [Novagen-
Merck], 62.5 units benzonase [Novagen-Merck], and Protease
Inhibitor Cocktail EDTA-free [Sigma-Aldrich]). The lysate was
centrifuged at 4°C in a table centrifuge for 10 min at full speed.
Supernatant was taken and incubated with 500 µl Glutathione
Superflow Agarose beads (Life Technologies) for 2 h at 4°C. The
agarose beads were packed in a column and loaded on an A˚KTA
chromatography system (GE Healthcare Biosciences). The col-
umn was rinsed using wash buffer (125 mM Tris-HCl, pH 8,
150 mM NaCl, and 10 mM β-mercaptoethanol) and eluted using
wash buffer supplemented with 10 mM reduced glutathione
(Sigma-Aldrich). Fractions with purified protein were collected
and concentrated using 50-kD Vivaspin ultrafiltration cups
(Sartorius). Finally, the buffer was changed in ultrafiltration
cups to 125 mMTris-HCl, pH 8, 150 mMNaCl, and 10% glycerol,
and purified proteins were frozen in liquid nitrogen and stored
at −80°C.
Analysis of protein PARylation
Cells were washed with ice-cold PBS supplemented with PARG
inhibitor (PARGi; 400 nM tannic acid), scraped in a small vol-
ume of PBS with PARGi, and transferred to low binding tubes,
followed by high-speed centrifugation at 4°C. Cells were lysed in
RIPA buffer (10 mM Tris-HCl, pH 8, 1% Triton X-100, 0.1% de-
oxycholate, 0.1% SDS, and 100 µM tannic acid) supplemented
with protease and phosphatase inhibitor cocktails (Roche)
comprising a NaCl-concentration of 450 mM. After centrifuga-
tion, cleared lysates were subjected to IP with GFP Trap beads
(Chromotek) for 2 h on a rotating wheel in the presence of
150 mM NaCl. Beads were washed six times with RIPA buffer
containing increasing NaCl concentrations (150 mM and 1 M)
followed by two washes with TBS-T buffer (20× TBS, 0.1%
Tween, and 100 µm tannic acid). After boiling in Laemmli
buffer, the interacting proteins were visualized using Western
blot analysis.
Production of radiolabeled PAR
PARP1 activation assays were performed as described earlier
(Shah et al., 2011) with minor modifications. To prepare radio-
labeled PAR, purified bovine PARP1 was activated at 30°C for
30min in 900 µl reactionmix (100mMTris-HCl, pH 8.0, 10mM
MgCl2, 10% glycerol, 10 mM DTT, 500 µM cold NAD, 250 µCi of
32P-NAD [350 nM], 10% ethanol, and 23 µg activated calf thymus
DNA). Auto-PARylated PARP1 was precipitated on ice for
≥30 min by addition of 100 µl of 3 M Na-acetate, pH 5.2, and
700 µl isopropanol. After centrifugation, the pellet was washed
twice with ethanol, air-dried, and dissolved (1 M KOH and
50 mM EDTA), while heating at 60°C for 1 h. Upon addition of
AAGE9 (250 mM NH4OAc, 6 M guanidine-HCl, and 10 mM
EDTA), pH was adjusted to 9.0, and solution was loaded onto
DHBB resin in Econocolumns (Bio-Rad). Resin was washed with
AAGE9 and NH4-acetate, pH 9.0. The polymer was eluted with
water at 37°C in separate fractions and stored at −30°C until
usage in Southwestern assays.
Southwestern assay
The Southwestern assay was performed as described (Robu
et al., 2013). Briefly, IP samples were resolved on 8% denatur-
ing PAGE gels along with purified human PARP1 (Aparptosis) as
a positive control. Gels were incubated for 1 h with gentle agi-
tation in SDS-PAGE running buffer (20–30ml of 25mMTris, pH
7.5, 192 mM glycine, 5% β-mercaptoethanol, and 0.1% SDS),
followed by protein transfer to a nitrocellulose membrane at
4°C.Membranewere rinsed three times with TST buffer (10mM
Tris, pH 7.5, 150 mM NaCl, and 0.05% Tween) and incubated in
20 ml TST buffer supplemented with 250 nM radioactive PAR
polymer on a shaker at room temperature for 1 h, followed by
three washes with TST and onewashwith TST buffer containing
500 mM NaCl. After a final wash with regular TST, membranes
were dried and exposed to either a film or a phosphoimager
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screen to detect radioactivity. Afterward, membranes were
blocked in 5% milk containing 0.1% Tween and probed for PARP
and GFP with the indicated antibodies.
PARP1 activation assays
To examine the stimulatory effect of ZBTB24 on the catalytic
activity of PARP1, PARP1 activation reactions were performed in
a 20-µl assay volume with 0.4 pmol of PARP1, 160 ng activated
DNA, and 100 µM unlabeled NAD at 30°C for 10 min with no
other protein (control) or varying molar ratios of GST-ZBTB24,
GST-ZBTB24 ΔZNF, or GST over PARP1. The reactions were
stopped by the addition of equal volumes of 2× Laemmli buffer.
Aliquots from each sample were resolved on 6 or 10% SDS-PAGE
followed by immunoblotting for PAR, PARP1, and GST.
PAR protection assays
To examine the effect of ZBTB24 on PAR protection, PARP1 ac-
tivation reactions were performed in a 15-µl assay volume with
4 pmol of PARP1, 3 µg of activated and 100 µM unlabeled NAD at
30°C for 30 min to allow the formation of autoPARylated PARP1.
The reaction was stopped by the addition of 1 µl of 1 mM PARPi
(PJ-34). One-tenth of the reaction mixes containing 0.4 pmol of
PARP1 were reacted for 15min with no other protein (control) or
varyingmolar ratios of GST-ZBTB24, GST-ZBTB24 ΔZNF, or GST
over PARP1. All samples were reacted at 30°C for 15 min in the
PARG-assay buffer (50 mM Tris-HCl, pH 7.5, containing 50 mM
KCl, 1.5 mM DTT, 0.1 mg/ml BSA, and 2.5 mM EDTA) with 5 ng
PARG (Sigma-Aldrich), whereas the undigested PAR samples
were mock-treated with PARG assay buffer. The reactions were
stopped by the addition of equal volumes of 2× Laemmli buffer.
Aliquots from each sample were resolved on 6 or 10% SDS-PAGE
followed by immunoblotting for PAR, PARP1, and GST.
Online supplemental material
Fig. S1 shows the differentiation of T cells from ICF2 patients;
combinational diversity; and junction characteristics of IgH re-
arrangements in ICF2 patients. Fig. S2 shows that knockdown of
ZBTB24 affects neither cell cycle progression nor the expression
of genes involved in DSB repair; ICF2 patient-derived fibroblasts
and ZBTB24 KO U2OS cells are not sensitive to IR. Fig. S3 shows
that PARG-dependent turnover of PAR chains modulates the
accumulation of ZBTB24 at sites of DNA damage; the ZNF do-
main of ZBTB24 accumulates at sites of DNA damage in a PARP
activity-dependent manner; ZBTB24 is not PARylated after DNA
damage induction. Fig. S4 shows the purification of recombinant
ZBTB24; PARP1 promotes XRCC4/LIG4 assembly and NHEJ at
DNA damage sites. Fig. S5 shows an analysis of HeLa Flp-In/
T-REx cells expressing siRNA-resistant GFP-ZBTB24 or GFP-
ZBTB24 ΔZNF; GFP-ZBTB24, but not GFP-ZBTB24 ΔZNF accu-
mulates at sites of DNA damage. Table S1 shows the serum Ig
isotype concentrations of ICF2 patients at first analysis. Table S2
lists ZBTB24-regulated genes identified by RNA sequencing.
Table S3 lists proteins identified as ZBTB24 interactors by
SILAC-based MS. Table S4 lists proteins identified as PARP1
interactors by SILAC-based MS. Table S5 contains sequences
of RT-qPCR primers and siRNAs. Data S1 contains the Sµ-Sα
junctions from ICF2 patients. Data S2 contains the Sµ-Sα
junctions from healthy donors. Data S3 contains the Sµ-Sγ
junctions from ICF2 patients.
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Figure S1. T cell differentiation in ICF2 patients and combinational diversity and junction characteristics of IgH rearrangements. Related to Fig. 1.
(A and B) Absolute numbers (per microliter) of the peripheral blood CD3+CD4+ T cell subset (A) and CD3+CD8+ T cell subset (B). The indicated differentiation
stages in both subsets were determined in three ICF2 patients and eight healthy age-matched controls (age range 0.8–4.3 yr) by flow cytometry. Phenotypical
definitions: naive T cells, CD45RA+CCR7+; central memory T cells, CD45RA−CCR7+; antigen experienced CD4+ T cells, CD45RA−/+CCR7−: early CD28+CD27+;
intermediate CD28+CD27−; late CD28−CD27−; antigen experienced CD8+ T cells, CD45RA−/+CCR7−: early CD28+CD27+; intermediate CD28−CD27+; late
CD28−CD27−. Statistical significance was calculated using Student’s t test (*, P < 0.05; **, P < 0.01; ns, not significant). (C and D) Heatmaps showing the
relative frequency of the combinational diversity of VH and JH genes (C) or DH and JH genes (D) of unique productive IgH rearrangements (defined by the
unique combination of VH, DH, JH, and nucleotide sequences of CDR3) amplified from control (n = 4,789) and ICF2 patients ICF2-49 (n = 757), IFC2-55 (n =
3,723), and ICF2-67 (n = 1,663). (E) The ICF2 patients (n = 3) display normal numbers of deletions and N-nucleotides compared with control (n = 12), in contrast
to XRCC4- and LIG4-deficient patients (n = 7; Murray et al., 2015), who display increased numbers of deletions and decreased numbers of N-nucleotides in
unique unproductive IGH rearrangements. Statistical significance was calculated using the Mann–Whitney U test (*, P < 0.05; ****, P < 0.0001; ns, not
significant).
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Figure S2. Knockdown of ZBTB24 does not affect cell cycle progression and the expression of genes involved in DSB repair. ICF2 patient-derived
fibroblasts and ZBTB24 KOU2OS cells are not sensitive to IR (related to Fig. 2). (A) U2OS cells and HEK293T cells containing the EJ5-GFP reporter were treated
with the indicated siRNAs. WCEs were prepared 48 h later and subjected to Western blot analysis for ZBTB24. RAD51 is a loading control. (B) HEK293T cells
containing the EJ5-GFP reporter were transfected with the indicated siRNAs. 48 h later, cells were transfected with a control vector or the I-SceI expression
vector (pCBASce). After an additional 24 h, cells were subjected to propidium iodide staining followed by flow cytometry analysis. The percentage of cells in G1
(red bar), S (blue bar), and G2/M (green bar) phase is presented. The mean ± SEM from two independent experiments is shown. Statistical significance was
calculated using Student’s t test (ns, not significant). (C) Schematic of the GC92 reporter for NHEJ. (D) Fibroblasts containing the GC92 reporter were treated
with the indicated siRNAs and, 48 h later, cotransfected with I-SceI (pCBASce) and mCherry expression vectors. The ratio of CD4-FITC/mCherry-expressing
cells was counted by flow cytometry 48 h later. The mean ± SEM from three to four independent experiments is shown. Statistical significance was calculated
using Student’s t test (**, P < 0.01; ****, P < 0.0001). (E) Cells from D were subjected to Western blot analysis of KU80 and ZBTB24 expression. Tubulin and
RAD51 are loading controls. (F) U2OS cells were treated with the indicated siRNAs. WCEs were prepared 48 h later and subjected to Western blot analysis for
DNA-PKcs and PARP1. Tubulin is a loading control. (G) HEK293T cells were treated with control siRNAs against luciferase or three different siRNAs against
ZBTB24. 4 d later, RNA was isolated and subjected to RNA sequencing analysis. The number of genes found to be commonly misregulated after ZBTB24-
depletion with each of the siRNAs is presented (false discovery rate < 0.05). Importantly, gene ontology term term analysis (0006302; DSB repair) did not
reveal the presence of DSB repair genes among the misregulated genes. (H) ICF2 patient-derived fibroblasts were exposed to different doses of IR and scored
for clonogenic survival. The mean ± SEM from two independent experiments is shown. (I) ZBTB24 KO U2OS cells were exposed to different doses of IR and
scored for clonogenic survival. The mean ± SEM from two independent experiments is shown. (J) Western blot analysis of ZBTB24 and CDCA7 expression in
ZBTB24 KO U2OS clones from I. Tubulin is a loading control. (K) TIDE analysis of ZBTB24 KO clones from I, showing 17- and 13-bp out-of-frame deletions in
ZBTB24 KO-1 and 11 and 10-bp out-of-frame deletions in ZBTB24 KO-2.
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Figure S3. PARG-dependent turnover of PAR chains modulates the accumulation of ZBTB24 at sites of DNA damage. The ZNF domain of ZBTB24
accumulates at sites of DNA damage in a PARP-dependent manner. ZBTB24 is not PARylated after DNA damage induction (related to Figs. 3 and 4). (A) U2OS
cells transiently expressing GFP-ZBTB24 or GFP-NLS were treated with either DMSO (Mock) or PARPi. WCEs were subjected to GFP IP followed by Western
blot analysis of the indicated proteins. (B) U2OS cells transfected with the indicated GFP-tagged proteins were treated with either DMSO (Mock) or PARPi.
WCEs were prepared and subjected to Western blot analysis to assess total PAR levels. (C) Western blot analysis showing total PAR levels in U2OS cells
transfected with the indicated siRNAs and transiently expressing GFP-ZBTB24. Tubulin is loading control. (D) GFP-ZBTB24 accumulation as monitored at the
indicated time points after laser microirradiation in cells from C. Scale bar, 10 µm. (E) Quantification of the results from D. The mean ± SEM from two in-
dependent experiments is shown. (F) As in C, except that cells were cotransfected with a GFP-ZBTB24 and either an mCherry or mCherry-PARG expression
vector were used. (G) As in D, except that cells from F were used. Scale bar, 10 µm. (H) Quantification of the results from G. The mean ± SEM from three
independent experiments is shown. (I) U2OS cells transiently expressing GFP-tagged BAZ domains of ZBTB24 were treated with DMSO (Mock) or PARPi and
subjected to laser microirradiation to follow GFP-BAZ accumulation at sites of DNA damage at the indicated time points after irradiation. Scale bar, 10 µm.
(J)Quantification of I. The mean ± SEM from two independent experiments is shown. (K) As in I, except for the GFP-tagged ZNF domain of ZBTB24 (GFP-ZNF).
Scale bar, 10 µm. (L) Quantification of K. The mean ± SEM from two independent experiments is shown. (M) U2OS cells expressing GFP were left untreated or
treated with IR or MNNG. WCE were prepared and subjected toWestern blot analysis for global PAR levels. (N)WCE extracts fromM and from cells expressing
GFP-ZBTB24 or GFP-PARP1 were subjected to GFP IP. Washes were performed under high-salt conditions to remove interacting proteins. Western blot
analysis was done for the indicated proteins and PAR. The experiment was performed two times for PARP1 and four times for ZBTB24. Blots from a rep-
resentative experiment are shown.
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Figure S4. Purification of recombinant ZBTB24 and PARP1 promotes XRCC4/LIG4 assembly and NHEJ at DNA damage sites. Related to Figs. 5 and 6.
(A) Coomassie-stained gel of recombinant GST, GST-tagged ZBTB24, and GST-tagged ZBTB24 ΔZNF, which were purified after expression in E. coli. The
indicated samples from the purification procedure were loaded and run on a 4–12% polyacrylamide gel. (B) U2OS stably expressing GFP-XRCC4 were treated
with DMSO (Mock) or PARPi and subjected to laser microirradiation. Representative images of unirradiated and irradiated cells (taken at the indicated time
point after irradiation) are shown. Scale bar, 10 µm. (C) Quantification of B. The mean ± SEM from two independent experiments is shown. Statistical sig-
nificance was calculated using Student’s t test (*, P < 0.05). (D) As in B, except that cells were transfected with the indicated siRNAs. Scale bar, 10 µm.
(E) Quantification of D. The mean ± SEM from three to five independent experiments is shown. Statistical significance was calculated using Student’s t test
(***, P < 0.001; ****, P < 0.0001). (F) Plasmid integration assays in U2OS cells transfected with indicated siRNAs. The mean ± SEM from two to four in-
dependent experiments is shown. Statistical significance was calculated using Student’s t test (**, P < 0.01; ****, P < 0.0001). (G) Accumulation of γH2AX and
endogenous XRCC4 at sites of laser-inflicted DNA damage. U2OS cells were treated with the indicated siRNAs, subjected to laser microirradiation, and 10 min
later, fixed and immunostained for γH2AX and endogenous XRCC4. Scale bar, 10 µm. (H)Quantification of endogenous XRCC4 levels in laser tracks from G. The
mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (****, P < 0.0001). (I) As in H, except for
γH2AX. The mean ± SEM from two independent experiments is shown. Statistical significance was calculated using Student’s t test (ns, not significant).
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Figure S5. Analysis of HeLa Flp-In/T-REx cells expressing GFP-ZBTB24 or GFP-ZBTB24 ΔZNF. Related to Fig. 6. (A) HeLa Flp-In/T-REx cells carrying
stably integrated inducible and siZBTB24-resistant GFP-ZBTB24 or GFP-ZBTB24 ΔZNF expression vectors express the GFP-tagged proteins upon doxycycline
(dox) treatment. Representative microscope images showing dox-inducible expression. Scale bar, 10 µm. (B) Western blot analysis of ZBTB24 expression in
cells from A. RAD51 is a loading control. (C) GFP-ZBTB24 and GFP-ZBTB24 ΔZNF recruitment at sites of laser-inflicted DNA damage in HeLa Flp-In/T-REx cells
induced with dox. Cells were transfected with the indicated siRNAs, subjected to laser microirradiation, and 10 min later, fixed and immunostained. γH2AX is a
DNA damage marker. Scale bar, 10 µm. (D) Quantification of the recruitment in cells from C. The mean from one experiment is shown. (E) Quantification of
γH2AX levels in laser tracks from cells in Fig. 6 G. The mean ± SEM of two to three independent experiments is shown.
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Tables S1–S5 are provided online as separate files. Table S1 shows Ig isotype concentrations at first analysis. Table S2 lists ZBTB24-
regulated genes identified by RNA sequencing. Table S3 lists proteins identified as ZBTB24 interactors by SILACMS, ordered by H/L.
Table S4 lists proteins identified as PARP1 interactors by SILAC MS, ordered by H/L. Table S5 lists primers and siRNAs. Data S1, S2,
and S3 are available online as PDFs. Data S1 contains the Sµ-Sα junctions from ICF2 patients. Data S2 contains the Sµ-Sα junctions
from healthy children. Data S3 contains the Sµ-Sγ junctions from ICF2 patients.
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